| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.722 | 0.009 | 0.722 | Antiobesity | 0.4 0.066 CID_7271 0.399 0.066 CID_13619 | ||
| 0.669 | 0.011 | 0.669 | Aldehyde oxidase inhibitor | 0.622 0.016 CID_7271 0.669 0.011 CID_13618 0.635 0.014 CID_13619 | ||
| 0.651 | 0.004 | 0.651 | GABA C receptor rho-3 antagonist | 0.568 0.012 CID_7271 0.598 0.008 CID_13618 0.577 0.01 CID_13619 | ||
| 0.624 | 0.012 | 0.624 | 5 Hydroxytryptamine release stimulant | 0.453 0.036 CID_7271 0.508 0.026 CID_13618 0.462 0.034 CID_13619 | ||
| 0.603 | 0.01 | 0.603 | 5 Hydroxytryptamine release inhibitor | 0.506 0.031 CID_7271 0.544 0.021 CID_13618 0.509 0.029 CID_13619 | ||
| 0.566 | 0.033 | 0.566 | Analgesic | 0.36 0.103 CID_7271 0.333 0.118 CID_13619 | ||
| 0.51 | 0.004 | 0.51 | Chemokine receptor antagonist | 0.225 0.014 CID_7271 0.099 0.064 CID_13618 0.214 0.016 CID_13619 | ||
| 0.508 | 0.004 | 0.508 | 5 Hydroxytryptamine uptake stimulant | 0.469 0.005 CID_7271 0.507 0.004 CID_13618 0.43 0.009 CID_13619 | ||
| 0.485 | 0.004 | 0.485 | CC chemokine receptor antagonist | 0.203 0.011 CID_7271 0.071 0.062 CID_13618 0.173 0.014 CID_13619 | ||
| 0.499 | 0.034 | 0.499 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.394 0.106 CID_7271 0.394 0.106 CID_13618 0.367 0.132 CID_13619 | ||
| 0.497 | 0.033 | 0.497 | Cholesterol antagonist | 0.37 0.057 CID_7271 0.447 0.041 CID_13618 0.387 0.052 CID_13619 | ||
| 0.473 | 0.017 | 0.473 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.451 | 0.004 | 0.627 | Cystathionine beta-synthase inhibitor | 0.627 0.003 CID_7271 0.489 0.004 CID_13618 0.554 0.003 CID_13619 | CID_7271 | |
| 0.436 | 0.004 | 0.443 | Succinate dehydrogenase inhibitor | 0.443 0.004 CID_7271 0.413 0.004 CID_13618 0.39 0.004 CID_13619 | CID_7271 | |
| 0.442 | 0.015 | 0.651 | Peroxidase inhibitor | 0.651 0.004 CID_7271 0.651 0.004 CID_13618 0.557 0.006 CID_13619 | CID_13618 | |
| 0.436 | 0.014 | 0.436 | Calcium channel activator | 0.379 0.033 CID_7271 0.37 0.038 CID_13618 0.349 0.05 CID_13619 | ||
| 0.485 | 0.066 | 0.5 | Caspase 9 stimulant | 0.427 0.095 CID_7271 0.5 0.06 CID_13618 0.499 0.06 CID_13619 | CID_13618 | |
| 0.417 | 0.004 | 0.417 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.337 0.005 CID_7271 0.271 0.008 CID_13618 0.357 0.004 CID_13619 | ||
| 0.418 | 0.008 | 0.418 | Alpha-N-acetylglucosaminidase inhibitor | 0.375 0.01 CID_7271 0.375 0.01 CID_13618 0.335 0.013 CID_13619 | ||
| 0.446 | 0.036 | 0.446 | Streptokinase A inhibitor | 0.337 0.066 CID_7271 0.398 0.048 CID_13618 0.39 0.05 CID_13619 | ||
| 0.44 | 0.031 | 0.44 | Aryl hydrocarbon receptor agonist | 0.245 0.081 CID_7271 0.233 0.086 CID_13618 0.261 0.074 CID_13619 | ||
| 0.407 | 0.004 | 0.407 | Potassium channel large-conductance Ca-activated activator | 0.245 0.005 CID_7271 0.221 0.005 CID_13618 0.208 0.006 CID_13619 | ||
| 0.397 | 0.005 | 0.397 | Glutamate receptor antagonist | 0.172 0.037 CID_7271 0.196 0.027 CID_13618 0.264 0.014 CID_13619 | ||
| 0.394 | 0.029 | 0.394 | HERG channel blocker | |||
| 0.412 | 0.055 | 0.412 | Calpain 2 inhibitor | 0.315 0.105 CID_7271 0.255 0.146 CID_13618 0.26 0.142 CID_13619 | ||
| 0.364 | 0.007 | 0.456 | UDP-glucose 4-epimerase inhibitor | 0.456 0.004 CID_7271 0.385 0.006 CID_13618 0.404 0.005 CID_13619 | CID_7271 | |
| 0.376 | 0.027 | 0.376 | Potassium channel blocker | |||
| 0.41 | 0.07 | 0.41 | Histamine release inhibitor | 0.332 0.108 CID_7271 0.38 0.086 CID_13618 0.328 0.11 CID_13619 | ||
| 0.34 | 0.005 | 0.34 | Ferrochelatase inhibitor | 0.246 0.014 CID_7271 0.246 0.014 CID_13618 0.215 0.019 CID_13619 | ||
| 0.339 | 0.005 | 0.339 | 5 Hydroxytryptamine uptake inhibitor | 0.084 0.032 CID_7271 0.11 0.023 CID_13618 0.2 0.011 CID_13619 | ||
| 0.34 | 0.007 | 0.34 | GABA C receptor agonist | 0.327 0.008 CID_7271 0.327 0.008 CID_13618 0.287 0.01 CID_13619 | ||
| 0.359 | 0.03 | 0.359 | Psychostimulant | 0.207 0.076 CID_7271 0.165 0.103 CID_13618 0.22 0.07 CID_13619 | ||
| 0.35 | 0.024 | 0.35 | RNA-directed DNA polymerase inhibitor | 0.318 0.028 CID_7271 0.333 0.026 CID_13618 0.273 0.039 CID_13619 | ||
| 0.348 | 0.024 | 0.348 | Anesthetic general | 0.253 0.049 CID_7271 0.294 0.034 CID_13618 0.255 0.048 CID_13619 | ||
| 0.34 | 0.019 | 0.366 | Tyrosine 3 hydroxylase inhibitor | 0.366 0.013 CID_7271 0.366 0.013 CID_13618 0.342 0.018 CID_13619 | CID_13618 | |
| 0.31 | 0.004 | 0.31 | Adrenaline uptake inhibitor | 0.124 0.013 CID_7271 0.201 0.006 CID_13618 0.219 0.005 CID_13619 | ||
| 0.31 | 0.005 | 0.31 | Potassium channel (Ca-activated) activator | 0.288 0.005 CID_7271 0.257 0.007 CID_13618 0.254 0.008 CID_13619 | ||
| 0.308 | 0.003 | 0.308 | Glutamate release inhibitor | 0.244 0.004 CID_7271 0.223 0.004 CID_13618 0.187 0.005 CID_13619 | ||
| 0.308 | 0.01 | 0.308 | 3C-like protease (Human coronavirus) inhibitor | 0.246 0.029 CID_7271 0.179 0.066 CID_13618 0.251 0.027 CID_13619 | ||
| 0.307 | 0.01 | 0.307 | Nitric-oxide synthase stimulant | 0.292 0.013 CID_7271 0.304 0.01 CID_13618 0.276 0.019 CID_13619 | ||
| 0.314 | 0.022 | 0.314 | 5 Hydroxytryptamine 1E antagonist | 0.266 0.057 CID_7271 0.286 0.04 CID_13618 0.244 0.081 CID_13619 | ||
| 0.294 | 0.006 | 0.294 | ATPase inhibitor | 0.247 0.014 CID_7271 0.225 0.022 CID_13618 0.257 0.012 CID_13619 | ||
| 0.327 | 0.042 | 0.327 | Superoxide dismutase inhibitor | 0.308 0.048 CID_7271 0.322 0.043 CID_13618 0.284 0.056 CID_13619 | ||
| 0.29 | 0.006 | 0.327 | Mannose-6-phosphate isomerase inhibitor | 0.311 0.005 CID_7271 0.327 0.004 CID_13618 0.32 0.005 CID_13619 | CID_13618 | |
| 0.288 | 0.005 | 0.288 | Purinergic P2 antagonist | |||
| 0.287 | 0.004 | 0.287 | Electrolyte absorption antagonist | 0.213 0.007 CID_7271 0.261 0.004 CID_13618 0.275 0.004 CID_13619 | ||
| 0.3 | 0.018 | 0.301 | Amylase inhibitor | 0.301 0.018 CID_7271 0.289 0.02 CID_13618 0.266 0.024 CID_13619 | CID_7271 | |
| 0.282 | 0.004 | 0.282 | CC chemokine receptor 2B antagonist | 0.066 0.014 CID_7271 0.074 0.01 CID_13618 0.052 0.028 CID_13619 | ||
| 0.307 | 0.037 | 0.307 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.23 0.071 CID_13618 0.28 0.047 CID_13619 | ||
| 0.301 | 0.032 | 0.301 | Gastrin inhibitor | 0.217 0.124 CID_7271 0.198 0.152 CID_13618 0.215 0.127 CID_13619 | ||
| 0.275 | 0.008 | 0.275 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.06 CID_7271 0.209 0.049 CID_13618 0.2 0.062 CID_13619 | ||
| 0.275 | 0.008 | 0.275 | GABA C receptor rho-2 antagonist | 0.205 0.026 CID_7271 0.221 0.02 CID_13618 0.206 0.026 CID_13619 | ||
| 0.265 | 0.005 | 0.265 | Dopamine D4 agonist | |||
| 0.261 | 0.003 | 0.261 | Lanosterol 14 alpha demethylase inhibitor | 0.163 0.008 CID_7271 0.159 0.009 CID_13618 0.172 0.006 CID_13619 | ||
| 0.325 | 0.067 | 0.512 | 12-Lipoxygenase inhibitor | 0.374 0.047 CID_7271 0.512 0.02 CID_13618 0.402 0.039 CID_13619 | CID_13618 | |
| 0.255 | 0.006 | 0.255 | Cell adhesion molecule inhibitor | |||
| 0.256 | 0.008 | 0.386 | NADH dehydrogenase inhibitor | 0.28 0.007 CID_7271 0.386 0.005 CID_13618 0.215 0.009 CID_13619 | CID_13618 | |
| 0.254 | 0.006 | 0.254 | EphA2 antagonist | 0.169 0.023 CID_7271 0.126 0.049 CID_13618 0.139 0.037 CID_13619 | ||
| 0.252 | 0.004 | 0.252 | Purinergic P2X antagonist | 0.048 0.035 CID_7271 | ||
| 0.253 | 0.005 | 0.253 | 5 Hydroxytryptamine 3A agonist | 0.165 0.028 CID_7271 0.187 0.019 CID_13618 0.172 0.025 CID_13619 | ||
| 0.278 | 0.032 | 0.278 | Neuropeptide Y2 antagonist | 0.236 0.07 CID_7271 0.237 0.069 CID_13618 0.217 0.093 CID_13619 | ||
| 0.287 | 0.044 | 0.287 | Anticonvulsant | 0.159 0.118 CID_13619 | ||
| 0.256 | 0.014 | 0.256 | Cell adhesion inhibitor | |||
| 0.254 | 0.017 | 0.254 | Cholesterol synthesis inhibitor | 0.191 0.029 CID_7271 0.2 0.027 CID_13618 0.202 0.026 CID_13619 | ||
| 0.251 | 0.017 | 0.251 | Hexokinase inhibitor | 0.2 0.035 CID_7271 0.202 0.034 CID_13618 0.201 0.034 CID_13619 | ||
| 0.245 | 0.012 | 0.245 | Catenin beta inhibitor | 0.178 0.055 CID_7271 0.171 0.064 CID_13618 0.159 0.085 CID_13619 | ||
| 0.241 | 0.01 | 0.241 | NMDA receptor antagonist | 0.176 0.018 CID_7271 0.155 0.023 CID_13618 0.209 0.013 CID_13619 | ||
| 0.237 | 0.006 | 0.237 | Cannabinoid receptor antagonist | 0.073 0.047 CID_7271 0.082 0.038 CID_13619 | ||
| 0.236 | 0.006 | 0.25 | HIV-1 integrase (Overall Integration) inhibitor | 0.224 0.008 CID_7271 0.25 0.005 CID_13618 0.204 0.011 CID_13619 | CID_13618 | |
| 0.233 | 0.005 | 0.233 | Prostaglandin E2 antagonist | |||
| 0.233 | 0.008 | 0.233 | GABA C receptor antagonist | 0.192 0.014 CID_7271 0.2 0.013 CID_13618 0.181 0.017 CID_13619 | ||
| 0.276 | 0.053 | 0.344 | DNA synthesis inhibitor | 0.344 0.032 CID_7271 0.27 0.055 CID_13618 0.309 0.041 CID_13619 | CID_7271 | |
| 0.258 | 0.034 | 0.258 | Neurotrophic factor enhancer | 0.233 0.049 CID_7271 0.254 0.036 CID_13618 0.237 0.046 CID_13619 | ||
| 0.289 | 0.067 | 0.386 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.235 0.083 CID_7271 0.386 0.041 CID_13618 0.286 0.068 CID_13619 | CID_13618 | |
| 0.243 | 0.022 | 0.243 | M18 aspartyl aminopeptidase inhibitor | 0.239 0.023 CID_7271 0.235 0.024 CID_13618 0.203 0.033 CID_13619 | ||
| 0.226 | 0.007 | 0.283 | Creatine kinase inhibitor | 0.251 0.005 CID_7271 0.283 0.004 CID_13618 0.226 0.007 CID_13619 | CID_13618 | |
| 0.255 | 0.04 | 0.279 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.279 0.031 CID_7271 0.265 0.036 CID_13618 0.231 0.051 CID_13619 | CID_7271 | |
| 0.22 | 0.006 | 0.22 | Protein kinase B gamma inhibitor | 0.078 0.049 CID_13618 0.071 0.056 CID_13619 | ||
| 0.217 | 0.004 | 0.217 | NMDA receptor agonist | 0.138 0.01 CID_7271 0.118 0.014 CID_13618 0.151 0.008 CID_13619 | ||
| 0.231 | 0.02 | 0.245 | Cell wall synthesis inhibitor | 0.245 0.017 CID_7271 0.166 0.051 CID_13618 0.234 0.019 CID_13619 | CID_7271 | |
| 0.279 | 0.068 | 0.346 | Transcription factor STAT inhibitor | 0.346 0.036 CID_7271 0.334 0.04 CID_13618 0.341 0.038 CID_13619 | CID_7271 | |
| 0.223 | 0.015 | 0.23 | Arachidonic acid antagonist | 0.224 0.015 CID_7271 0.23 0.012 CID_13618 0.214 0.021 CID_13619 | CID_13618 | |
| 0.25 | 0.043 | 0.25 | Non-steroidal antiinflammatory agent | 0.176 0.091 CID_7271 0.172 0.094 CID_13618 0.155 0.108 CID_13619 | ||
| 0.211 | 0.005 | 0.211 | Cannabinoid CB1 receptor antagonist | 0.064 0.04 CID_7271 0.075 0.031 CID_13619 | ||
| 0.211 | 0.007 | 0.211 | Nav1.8 sodium channel blocker | 0.187 0.009 CID_7271 0.111 0.024 CID_13619 | ||
| 0.211 | 0.007 | 0.211 | Sphingosine 1-phosphate receptor 4 antagonist | 0.158 0.027 CID_7271 0.194 0.01 CID_13618 0.174 0.017 CID_13619 | ||
| 0.321 | 0.117 | 0.47 | 15-Lipoxygenase inhibitor | 0.317 0.12 CID_7271 0.47 0.048 CID_13618 0.371 0.088 CID_13619 | CID_13618 | |
| 0.205 | 0.003 | 0.205 | Purinergic P2X7 antagonist | |||
| 0.206 | 0.004 | 0.206 | Aryl hydrocarbon receptor antagonist | 0.099 0.014 CID_7271 0.094 0.016 CID_13618 0.105 0.011 CID_13619 | ||
| 0.271 | 0.069 | 0.271 | Transcription factor STAT3 inhibitor | 0.264 0.073 CID_7271 0.226 0.105 CID_13618 0.222 0.109 CID_13619 | ||
| 0.227 | 0.026 | 0.227 | Nav1.2 sodium channel blocker | 0.131 0.071 CID_7271 0.116 0.088 CID_13618 0.114 0.091 CID_13619 | ||
| 0.293 | 0.093 | 0.308 | Vasodilator, coronary | 0.229 0.155 CID_7271 0.308 0.081 CID_13618 0.273 0.111 CID_13619 | CID_13618 | |
| 0.207 | 0.009 | 0.207 | Pregnane X receptor agonist | 0.159 0.039 CID_7271 0.163 0.034 CID_13618 0.162 0.034 CID_13619 | ||
| 0.2 | 0.004 | 0.2 | Ca2+-transporting ATPase inhibitor | 0.19 0.004 CID_7271 0.185 0.005 CID_13618 0.19 0.004 CID_13619 | ||
| 0.201 | 0.006 | 0.201 | Cyclin B3 inhibitor | 0.151 0.013 CID_7271 0.139 0.016 CID_13619 | ||
| 0.255 | 0.06 | 0.255 | Calpain inhibitor | 0.235 0.08 CID_7271 0.177 0.139 CID_13618 0.211 0.104 CID_13619 | ||
| 0.263 | 0.07 | 0.263 | Interleukin agonist | 0.198 0.122 CID_7271 0.218 0.104 CID_13618 0.187 0.133 CID_13619 | ||
| 0.232 | 0.041 | 0.232 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.267 | 0.077 | 0.267 | Ca(v)3.3 blocker | |||
| 0.218 | 0.027 | 0.218 | Alkaline phosphatase inhibitor | 0.202 0.032 CID_7271 0.167 0.049 CID_13618 0.19 0.037 CID_13619 | ||
| 0.208 | 0.017 | 0.208 | Carbonic anhydrase XV inhibitor | 0.177 0.023 CID_7271 0.195 0.019 CID_13618 0.165 0.026 CID_13619 | ||
| 0.198 | 0.008 | 0.198 | GABA C receptor rho-1 antagonist | 0.142 0.025 CID_7271 0.151 0.021 CID_13618 0.137 0.028 CID_13619 | ||
| 0.269 | 0.08 | 0.305 | Insulysin inhibitor | 0.272 0.078 CID_7271 0.305 0.055 CID_13618 0.225 0.123 CID_13619 | CID_13618 | |
| 0.2 | 0.014 | 0.2 | Falcipain 2 inhibitor | |||
| 0.2 | 0.015 | 0.2 | Falcipain inhibitor | |||
| 0.198 | 0.013 | 0.199 | Interleukin 8 antagonist | 0.178 0.02 CID_7271 0.199 0.013 CID_13618 0.144 0.038 CID_13619 | CID_13618 | |
| 0.194 | 0.011 | 0.194 | Triose-phosphate isomerase inhibitor | 0.177 0.014 CID_7271 0.177 0.014 CID_13618 0.157 0.018 CID_13619 | ||
| 0.185 | 0.006 | 0.185 | Autotaxin inhibitor | 0.083 0.017 CID_7271 0.07 0.023 CID_13619 | ||
| 0.217 | 0.038 | 0.217 | Antipruritic | 0.193 0.054 CID_7271 0.159 0.085 CID_13619 | ||
| 0.183 | 0.005 | 0.194 | NMDA receptor subunit 3B antagonist | 0.194 0.005 CID_7271 0.136 0.007 CID_13618 0.19 0.005 CID_13619 | CID_7271 | |
| 0.201 | 0.024 | 0.201 | Nav1.3 sodium channel blocker | 0.146 0.05 CID_7271 0.108 0.088 CID_13618 0.114 0.081 CID_13619 | ||
| 0.179 | 0.003 | 0.179 | NMDA receptor glycine site agonist | 0.13 0.006 CID_7271 0.12 0.009 CID_13618 0.139 0.005 CID_13619 | ||
| 0.202 | 0.027 | 0.202 | Aldehyde dehydrogenase inhibitor | 0.185 0.032 CID_7271 0.167 0.038 CID_13618 0.18 0.034 CID_13619 | ||
| 0.211 | 0.037 | 0.27 | Phospholipase C inhibitor | 0.27 0.022 CID_7271 0.24 0.027 CID_13618 0.222 0.033 CID_13619 | CID_7271 | |
| 0.179 | 0.005 | 0.179 | Dopamine transporter inhibitor | 0.078 0.018 CID_7271 0.11 0.01 CID_13618 0.122 0.008 CID_13619 | ||
| 0.191 | 0.017 | 0.191 | Catalase inhibitor | 0.135 0.03 CID_7271 0.134 0.03 CID_13618 0.132 0.03 CID_13619 | ||
| 0.177 | 0.004 | 0.177 | D-Ala-D-Ala ligase inhibitor | 0.169 0.004 CID_7271 0.168 0.004 CID_13618 0.17 0.004 CID_13619 | ||
| 0.213 | 0.04 | 0.298 | Diuretic | 0.192 0.047 CID_7271 0.298 0.023 CID_13618 0.267 0.028 CID_13619 | CID_13618 | |
| 0.193 | 0.021 | 0.193 | Cyclooxygenase 3 inhibitor | 0.15 0.048 CID_7271 0.171 0.033 CID_13618 0.153 0.046 CID_13619 | ||
| 0.174 | 0.003 | 0.174 | Exportin-1 inhibitor | 0.119 0.005 CID_7271 0.104 0.008 CID_13618 0.113 0.005 CID_13619 | ||
| 0.196 | 0.025 | 0.196 | Ephrin antagonist | 0.137 0.041 CID_7271 0.1 0.063 CID_13618 | ||
| 0.174 | 0.004 | 0.174 | Glucagon-like peptide 1 receptor antagonist | 0.062 0.008 CID_7271 0.053 0.012 CID_13619 | ||
| 0.182 | 0.013 | 0.182 | Aminoacyl-tRNA synthetase inhibitor | 0.157 0.017 CID_7271 0.083 0.071 CID_13618 0.123 0.029 CID_13619 | ||
| 0.207 | 0.038 | 0.237 | Interferon gamma antagonist | 0.237 0.031 CID_7271 0.22 0.035 CID_13618 0.215 0.036 CID_13619 | CID_7271 | |
| 0.179 | 0.01 | 0.179 | CYP2A6 inhibitor | 0.079 0.049 CID_7271 0.074 0.054 CID_13618 0.077 0.051 CID_13619 | ||
| 0.211 | 0.043 | 0.396 | Heat shock protein 90 alpha antagonist | 0.396 0.005 CID_7271 0.333 0.01 CID_13618 0.394 0.005 CID_13619 | CID_7271 | |
| 0.18 | 0.013 | 0.238 | Urease inhibitor | 0.206 0.009 CID_7271 0.179 0.013 CID_13618 0.238 0.007 CID_13619 | CID_13619 | |
| 0.279 | 0.112 | 0.464 | Prostaglandin dehydrogenase inhibitor | 0.419 0.061 CID_7271 0.464 0.05 CID_13618 0.444 0.055 CID_13619 | CID_13618 | |
| 0.179 | 0.012 | 0.179 | Heat shock protein 70 antagonist | 0.159 0.029 CID_7271 0.159 0.029 CID_13618 0.159 0.029 CID_13619 | ||
| 0.173 | 0.006 | 0.173 | Cannabinoid CB2 receptor antagonist | 0.082 0.019 CID_7271 0.089 0.018 CID_13619 | ||
| 0.172 | 0.005 | 0.172 | Sphingosine 1-phosphate receptor 4 agonist | 0.156 0.008 CID_7271 0.118 0.018 CID_13618 0.132 0.013 CID_13619 | ||
| 0.189 | 0.023 | 0.189 | Nav1.6 sodium channel blocker | 0.142 0.064 CID_7271 0.129 0.082 CID_13618 0.115 0.105 CID_13619 | ||
| 0.196 | 0.031 | 0.196 | Sodium channel (voltage-gated) blocker | 0.139 0.064 CID_7271 0.105 0.104 CID_13618 0.107 0.101 CID_13619 | ||
| 0.184 | 0.021 | 0.184 | Sphingosine 1-phosphate receptor 5 antagonist | 0.18 0.024 CID_7271 0.168 0.036 CID_13618 0.167 0.037 CID_13619 | ||
| 0.176 | 0.013 | 0.176 | Potassium channel activator | 0.104 0.044 CID_7271 0.097 0.051 CID_13618 0.097 0.051 CID_13619 | ||
| 0.166 | 0.005 | 0.166 | Neurokinin 2 antagonist | |||
| 0.177 | 0.016 | 0.177 | Beta glucuronidase inhibitor | 0.161 0.02 CID_7271 0.154 0.023 CID_13618 0.155 0.023 CID_13619 | ||
| 0.173 | 0.012 | 0.188 | DOPA decarboxylase inhibitor | 0.18 0.01 CID_7271 0.188 0.009 CID_13618 0.178 0.011 CID_13619 | CID_13618 | |
| 0.297 | 0.138 | 0.372 | Antibacterial | 0.369 0.092 CID_7271 0.372 0.09 CID_13618 0.367 0.092 CID_13619 | CID_13618 | |
| 0.194 | 0.036 | 0.194 | NADPH oxidase inhibitor | 0.133 0.068 CID_7271 0.183 0.04 CID_13618 0.112 0.094 CID_13619 | ||
| 0.209 | 0.052 | 0.303 | Amyloid beta precursor protein antagonist | 0.145 0.107 CID_7271 0.303 0.016 CID_13618 0.277 0.024 CID_13619 | CID_13618 | |
| 0.187 | 0.03 | 0.187 | MAP kinase 3 inhibitor | 0.143 0.079 CID_7271 0.146 0.074 CID_13618 0.132 0.102 CID_13619 | ||
| 0.269 | 0.114 | 0.343 | Transcription factor NF kappa B inhibitor | 0.308 0.09 CID_7271 0.284 0.104 CID_13618 0.343 0.079 CID_13619 | CID_13619 | |
| 0.162 | 0.006 | 0.162 | Potassium channel Kv1.5 blocker | |||
| 0.174 | 0.018 | 0.174 | DNA directed RNA polymerase inhibitor | 0.164 0.02 CID_7271 0.094 0.064 CID_13618 0.134 0.03 CID_13619 | ||
| 0.16 | 0.005 | 0.16 | Glycine receptor antagonist | 0.12 0.018 CID_7271 0.12 0.018 CID_13618 0.124 0.016 CID_13619 | ||
| 0.16 | 0.006 | 0.16 | GABA aminotransferase inhibitor | 0.143 0.009 CID_7271 0.141 0.01 CID_13618 0.127 0.014 CID_13619 | ||
| 0.182 | 0.029 | 0.182 | Cathepsin H inhibitor | 0.115 0.083 CID_7271 0.128 0.066 CID_13618 0.116 0.08 CID_13619 | ||
| 0.185 | 0.032 | 0.185 | CF transmembrane conductance regulator agonist | 0.165 0.053 CID_7271 0.175 0.041 CID_13618 0.161 0.058 CID_13619 | ||
| 0.192 | 0.04 | 0.192 | Neurotensin receptor agonist | 0.176 0.054 CID_7271 0.179 0.051 CID_13618 0.171 0.061 CID_13619 | ||
| 0.162 | 0.01 | 0.162 | Histamine N-methyltransferase inhibitor | 0.11 0.038 CID_7271 0.124 0.027 CID_13618 0.113 0.035 CID_13619 | ||
| 0.165 | 0.014 | 0.165 | NMDA 2 receptor antagonist | 0.13 0.021 CID_7271 0.111 0.027 CID_13618 0.104 0.03 CID_13619 | ||
| 0.156 | 0.005 | 0.156 | NMDA receptor subunit 3A antagonist | 0.148 0.005 CID_7271 0.097 0.009 CID_13618 0.152 0.005 CID_13619 | ||
| 0.17 | 0.021 | 0.171 | Sphingosine 1-phosphate receptor 2 antagonist | 0.171 0.021 CID_7271 0.167 0.023 CID_13618 0.152 0.039 CID_13619 | CID_7271 | |
| 0.179 | 0.03 | 0.179 | Neuropeptide Y1 antagonist | 0.158 0.054 CID_7271 0.143 0.075 CID_13618 0.15 0.066 CID_13619 | ||
| 0.265 | 0.117 | 0.265 | Vasodilator, peripheral | 0.25 0.127 CID_7271 0.242 0.134 CID_13618 0.199 0.177 CID_13619 | ||
| 0.176 | 0.029 | 0.181 | Adenylate cyclase stimulant | 0.176 0.029 CID_7271 0.181 0.025 CID_13618 0.173 0.032 CID_13619 | CID_13618 | |
| 0.168 | 0.021 | 0.168 | Adenylate kinase inhibitor | 0.156 0.024 CID_7271 0.156 0.024 CID_13618 0.141 0.03 CID_13619 | ||
| 0.154 | 0.009 | 0.154 | T cell inhibitor | 0.091 0.035 CID_7271 0.093 0.033 CID_13619 | ||
| 0.223 | 0.078 | 0.223 | Cyclic AMP phosphodiesterase inhibitor | 0.164 0.131 CID_13618 | ||
| 0.216 | 0.072 | 0.216 | MAP kinase kinase 2 inhibitor | 0.139 0.131 CID_7271 0.167 0.106 CID_13618 | ||
| 0.163 | 0.02 | 0.163 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.151 | 0.009 | 0.151 | Bromodomain-containing protein 2 inhibitor | 0.092 0.052 CID_13618 | ||
| 0.152 | 0.01 | 0.152 | Prostaglandin antagonist | |||
| 0.145 | 0.004 | 0.145 | Potassium channel intermediate-conductance Ca-activated blocker | 0.058 0.046 CID_7271 0.061 0.04 CID_13618 0.056 0.05 CID_13619 | ||
| 0.156 | 0.018 | 0.346 | Histidine decarboxylase inhibitor | 0.23 0.01 CID_7271 0.346 0.005 CID_13618 0.143 0.021 CID_13619 | CID_13618 | |
| 0.179 | 0.041 | 0.179 | Sodium channel blocker | 0.125 0.078 CID_7271 | ||
| 0.157 | 0.019 | 0.183 | Transcription factor STAT6 inhibitor | 0.183 0.009 CID_7271 0.163 0.015 CID_13618 0.163 0.016 CID_13619 | CID_7271 | |
| 0.142 | 0.004 | 0.142 | Vanilloid 4 agonist | 0.104 0.014 CID_7271 0.101 0.016 CID_13618 0.108 0.012 CID_13619 | ||
| 0.142 | 0.004 | 0.142 | Glutamate (mGluR6) antagonist | 0.111 0.007 CID_7271 0.107 0.008 CID_13618 0.107 0.008 CID_13619 | ||
| 0.184 | 0.046 | 0.184 | Thiol protease inhibitor | 0.146 0.072 CID_7271 0.139 0.082 CID_13618 0.123 0.111 CID_13619 | ||
| 0.156 | 0.019 | 0.197 | Porphobilinogen synthase inhibitor | 0.197 0.012 CID_7271 0.197 0.012 CID_13618 0.168 0.017 CID_13619 | CID_13618 | |
| 0.141 | 0.005 | 0.141 | GABA B receptor agonist | 0.128 0.006 CID_7271 0.136 0.005 CID_13618 0.118 0.008 CID_13619 | ||
| 0.149 | 0.012 | 0.149 | Glutamate (mGluR7) agonist | 0.108 0.046 CID_7271 0.117 0.034 CID_13618 0.093 0.075 CID_13619 | ||
| 0.139 | 0.003 | 0.139 | Potassium channel small-conductance Ca-activated activator | 0.034 0.019 CID_7271 0.035 0.019 CID_13618 0.039 0.015 CID_13619 | ||
| 0.139 | 0.004 | 0.139 | Glutamate (mGluR3) antagonist | 0.063 0.007 CID_7271 0.058 0.009 CID_13618 0.065 0.007 CID_13619 | ||
| 0.197 | 0.063 | 0.197 | Sigma receptor agonist | |||
| 0.206 | 0.072 | 0.206 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.182 | 0.049 | 0.182 | Cyclooxygenase inhibitor | 0.142 0.077 CID_7271 | ||
| 0.149 | 0.017 | 0.164 | MAP kinase kinase 1 inhibitor | 0.164 0.012 CID_7271 0.159 0.013 CID_13618 0.162 0.012 CID_13619 | CID_7271 | |
| 0.156 | 0.024 | 0.156 | Nav1.5 sodium channel blocker | 0.115 0.061 CID_7271 | ||
| 0.142 | 0.011 | 0.142 | Dopamine uptake inhibitor | 0.079 0.026 CID_7271 0.094 0.02 CID_13618 0.106 0.017 CID_13619 | ||
| 0.133 | 0.003 | 0.133 | CC chemokine 4 receptor antagonist | 0.067 0.012 CID_7271 0.059 0.017 CID_13618 0.068 0.011 CID_13619 | ||
| 0.134 | 0.004 | 0.134 | Nicotinic alpha3beta2 receptor antagonist | 0.082 0.012 CID_7271 0.07 0.018 CID_13618 0.087 0.01 CID_13619 | ||
| 0.184 | 0.055 | 0.184 | Cytidine deaminase inhibitor | 0.17 0.062 CID_13618 0.141 0.082 CID_13619 | ||
| 0.182 | 0.053 | 0.182 | Interleukin 6 antagonist | |||
| 0.151 | 0.024 | 0.151 | Sphingomyelinase inhibitor | 0.127 0.036 CID_7271 0.123 0.039 CID_13618 0.114 0.046 CID_13619 | ||
| 0.131 | 0.005 | 0.131 | Phospholipase D inhibitor | 0.095 0.018 CID_7271 0.099 0.015 CID_13618 0.089 0.023 CID_13619 | ||
| 0.214 | 0.09 | 0.234 | Antiamyloidogenic | 0.223 0.085 CID_7271 0.234 0.078 CID_13618 0.156 0.139 CID_13619 | CID_13618 | |
| 0.152 | 0.027 | 0.159 | AMP-activated protein kinase stimulant | 0.159 0.023 CID_7271 0.14 0.035 CID_13618 0.143 0.033 CID_13619 | CID_7271 | |
| 0.135 | 0.012 | 0.178 | Alcohol oxidase inhibitor | 0.178 0.008 CID_7271 0.178 0.008 CID_13618 0.145 0.011 CID_13619 | CID_13618 | |
| 0.136 | 0.013 | 0.136 | Carbamoyl phosphate synthetase inhibitor | 0.128 0.014 CID_7271 0.128 0.014 CID_13618 0.115 0.017 CID_13619 | ||
| 0.132 | 0.01 | 0.132 | Glycine receptor agonist | 0.111 0.015 CID_7271 0.125 0.011 CID_13618 0.112 0.015 CID_13619 | ||
| 0.174 | 0.053 | 0.37 | Heat shock protein 90 antagonist | 0.37 0.005 CID_7271 0.284 0.013 CID_13618 0.354 0.005 CID_13619 | CID_7271 | |
| 0.127 | 0.009 | 0.127 | NMDA 2A receptor antagonist | 0.086 0.018 CID_7271 0.073 0.023 CID_13618 0.094 0.015 CID_13619 | ||
| 0.122 | 0.004 | 0.122 | Potassium channel (Inward rectifier) activator | 0.077 0.009 CID_7271 0.075 0.009 CID_13618 0.074 0.01 CID_13619 | ||
| 0.163 | 0.045 | 0.163 | Cyclooxygenase 2 inhibitor | 0.125 0.075 CID_7271 | ||
| 0.127 | 0.009 | 0.127 | NMDA 2C receptor antagonist | 0.099 0.016 CID_7271 0.092 0.019 CID_13618 0.09 0.019 CID_13619 | ||
| 0.126 | 0.009 | 0.126 | Phosphorylase inhibitor | 0.063 0.023 CID_7271 0.058 0.026 CID_13618 0.068 0.021 CID_13619 | ||
| 0.14 | 0.024 | 0.296 | Interleukin 2 antagonist | 0.236 0.005 CID_13618 0.296 0.004 CID_13619 | CID_13619 | |
| 0.12 | 0.003 | 0.12 | Potassium channel (ATP-sensitive) activator | 0.074 0.008 CID_7271 0.072 0.009 CID_13618 0.071 0.009 CID_13619 | ||
| 0.146 | 0.03 | 0.149 | Carbonic anhydrase III inhibitor | 0.131 0.037 CID_7271 0.149 0.029 CID_13618 0.132 0.037 CID_13619 | CID_13618 | |
| 0.129 | 0.014 | 0.129 | Nicotinic alpha4beta2 receptor antagonist | 0.091 0.039 CID_7271 0.075 0.056 CID_13618 0.083 0.047 CID_13619 | ||
| 0.139 | 0.024 | 0.143 | Anabolic | 0.143 0.022 CID_7271 0.141 0.023 CID_13618 0.137 0.026 CID_13619 | CID_7271 | |
| 0.129 | 0.014 | 0.129 | CXC chemokine receptor antagonist | |||
| 0.136 | 0.021 | 0.144 | Phosphofructokinase-1 inhibitor | 0.144 0.019 CID_7271 0.144 0.019 CID_13618 0.129 0.023 CID_13619 | CID_13618 | |
| 0.119 | 0.004 | 0.119 | Corticotropin releasing factor 2 receptor antagonist | 0.078 0.019 CID_7271 0.062 0.042 CID_13618 0.08 0.017 CID_13619 | ||
| 0.189 | 0.075 | 0.263 | DNA methyltransferase I inhibitor | 0.23 0.056 CID_7271 0.263 0.041 CID_13618 0.245 0.049 CID_13619 | CID_13618 | |
| 0.129 | 0.016 | 0.153 | Phenylalanine 4-hydroxylase inhibitor | 0.141 0.013 CID_7271 0.153 0.011 CID_13618 0.134 0.015 CID_13619 | CID_13618 | |
| 0.12 | 0.009 | 0.12 | 5 Hydroxytryptamine 2A agonist | 0.096 0.016 CID_7271 0.086 0.022 CID_13618 0.081 0.026 CID_13619 | ||
| 0.124 | 0.013 | 0.124 | Biliverdin reductase inhibitor | 0.095 0.02 CID_7271 0.095 0.02 CID_13618 0.082 0.025 CID_13619 | ||
| 0.115 | 0.004 | 0.115 | MDM2 inhibitor | 0.092 0.01 CID_7271 0.087 0.013 CID_13618 0.096 0.008 CID_13619 | ||
| 0.138 | 0.027 | 0.173 | Folate antagonist | 0.173 0.015 CID_7271 0.122 0.037 CID_13619 | CID_7271 | |
| 0.144 | 0.035 | 0.144 | TRPA1 agonist | 0.106 0.078 CID_7271 0.121 0.057 CID_13618 0.106 0.078 CID_13619 | ||
| 0.136 | 0.027 | 0.136 | Acetylcholine release stimulant | 0.103 0.08 CID_13618 | ||
| 0.112 | 0.004 | 0.112 | Kynurenine 3 monooxygenase inhibitor | 0.085 0.004 CID_7271 0.07 0.004 CID_13618 0.059 0.005 CID_13619 | ||
| 0.191 | 0.084 | 0.191 | Histone acetyltransferase inhibitor | 0.151 0.138 CID_7271 | ||
| 0.198 | 0.091 | 0.198 | ErbB-1 antagonist | 0.164 0.145 CID_7271 0.196 0.093 CID_13618 | ||
| 0.108 | 0.003 | 0.182 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.159 0.002 CID_7271 0.182 0.002 CID_13618 0.142 0.002 CID_13619 | CID_13618 | |
| 0.113 | 0.008 | 0.113 | 5 Hydroxytryptamine 2 agonist | 0.086 0.013 CID_7271 0.065 0.022 CID_13618 0.095 0.01 CID_13619 | ||
| 0.157 | 0.053 | 0.157 | Cyclooxygenase 1 inhibitor | 0.122 0.078 CID_7271 | ||
| 0.108 | 0.003 | 0.127 | Pregnane X receptor antagonist | 0.127 0.002 CID_7271 0.117 0.003 CID_13618 0.112 0.003 CID_13619 | CID_7271 | |
| 0.125 | 0.021 | 0.127 | Glutamate dehydrogenase inhibitor | 0.123 0.022 CID_7271 0.127 0.021 CID_13618 0.109 0.026 CID_13619 | CID_13618 | |
| 0.122 | 0.019 | 0.122 | Prostaglandin-E synthase inhibitor | 0.076 0.042 CID_7271 0.079 0.039 CID_13618 0.068 0.052 CID_13619 | ||
| 0.143 | 0.041 | 0.143 | Aminopeptidase B inhibitor | 0.134 0.045 CID_7271 0.134 0.045 CID_13618 0.119 0.053 CID_13619 | ||
| 0.106 | 0.005 | 0.106 | Calcium channel P-type blocker | 0.064 0.043 CID_7271 0.072 0.025 CID_13618 0.067 0.034 CID_13619 | ||
| 0.188 | 0.087 | 0.244 | DNA methylase inhibitor | 0.208 0.074 CID_7271 0.244 0.052 CID_13618 0.227 0.062 CID_13619 | CID_13618 | |
| 0.116 | 0.017 | 0.116 | Benzodiazepine agonist | |||
| 0.114 | 0.016 | 0.114 | Cannabinoid CB1 receptor agonist | |||
| 0.171 | 0.073 | 0.223 | Mcl-1 antagonist | 0.161 0.08 CID_7271 0.223 0.045 CID_13618 | CID_13618 | |
| 0.186 | 0.088 | 0.186 | Insulin sensitizer | 0.169 0.108 CID_7271 0.162 0.117 CID_13618 0.146 0.139 CID_13619 | ||
| 0.15 | 0.052 | 0.205 | Farnesoid X receptor antagonist | 0.205 0.02 CID_7271 0.136 0.073 CID_13618 0.175 0.032 CID_13619 | CID_7271 | |
| 0.111 | 0.014 | 0.135 | Purinergic P2X1 antagonist | 0.135 0.009 CID_7271 0.123 0.011 CID_13618 0.131 0.009 CID_13619 | CID_7271 | |
| 0.155 | 0.058 | 0.156 | MAO inhibitor | 0.149 0.06 CID_7271 0.115 0.078 CID_13618 0.156 0.058 CID_13619 | CID_13619 | |
| 0.164 | 0.066 | 0.164 | Cyclin-dependent kinase 8 inhibitor | 0.139 0.091 CID_7271 | ||
| 0.118 | 0.021 | 0.119 | Bile acid receptor antagonist | 0.119 0.021 CID_7271 0.108 0.035 CID_13618 0.117 0.023 CID_13619 | CID_7271 | |
| 0.101 | 0.005 | 0.101 | Glycine transporter 1 inhibitor | |||
| 0.11 | 0.014 | 0.11 | Acyl-CoA dehydrogenase inhibitor | 0.084 0.021 CID_7271 0.084 0.021 CID_13618 0.073 0.025 CID_13619 | ||
| 0.1 | 0.004 | 0.1 | 5 Hydroxytryptamine 2B agonist | 0.055 0.011 CID_7271 0.049 0.014 CID_13618 0.046 0.016 CID_13619 | ||
| 0.173 | 0.078 | 0.173 | LIM domain kinase 1 inhibitor | 0.137 0.112 CID_7271 | ||
| 0.124 | 0.028 | 0.124 | Potassium channel (Voltage-sensitive) activator | |||
| 0.13 | 0.035 | 0.13 | Ca(v)2.2 blocker | |||
| 0.098 | 0.004 | 0.098 | NMDA receptor glycine site antagonist | 0.052 0.005 CID_7271 0.046 0.007 CID_13618 0.054 0.005 CID_13619 | ||
| 0.104 | 0.011 | 0.104 | Glycine transporter inhibitor | 0.05 0.031 CID_13619 | ||
| 0.138 | 0.045 | 0.138 | Alpha 2b adrenoreceptor antagonist | 0.089 0.086 CID_7271 | ||
| 0.126 | 0.032 | 0.126 | Calcium antagonist | |||
| 0.123 | 0.03 | 0.14 | Protein kinase C zeta inhibitor | 0.14 0.023 CID_7271 0.102 0.048 CID_13618 0.127 0.028 CID_13619 | CID_7271 | |
| 0.107 | 0.014 | 0.107 | Bcl2 antagonist | 0.069 0.043 CID_7271 0.075 0.037 CID_13619 | ||
| 0.096 | 0.003 | 0.096 | Heme oxygenase inhibitor | 0.053 0.01 CID_7271 0.053 0.01 CID_13618 0.055 0.009 CID_13619 | ||
| 0.117 | 0.024 | 0.138 | Glutathione S-transferase inhibitor | 0.112 0.028 CID_7271 0.116 0.025 CID_13618 0.138 0.015 CID_13619 | CID_13619 | |
| 0.183 | 0.091 | 0.27 | Pyruvate kinase inhibitor | 0.199 0.081 CID_7271 0.27 0.056 CID_13618 0.229 0.068 CID_13619 | CID_13618 | |
| 0.11 | 0.019 | 0.11 | Amidase inhibitor | 0.064 0.058 CID_7271 0.062 0.061 CID_13618 | ||
| 0.134 | 0.044 | 0.141 | MAO B inhibitor | 0.132 0.045 CID_7271 0.106 0.057 CID_13618 0.141 0.04 CID_13619 | CID_13619 | |
| 0.137 | 0.046 | 0.137 | Calcium channel N-type blocker | |||
| 0.117 | 0.027 | 0.209 | Macrophage migration inhibitory factor inhibitor | 0.209 0.007 CID_7271 0.139 0.018 CID_13618 0.165 0.012 CID_13619 | CID_7271 | |
| 0.098 | 0.01 | 0.098 | Botulinum neurotoxin type A inhibitor | 0.078 0.018 CID_7271 0.076 0.02 CID_13618 0.081 0.016 CID_13619 | ||
| 0.096 | 0.009 | 0.096 | Sphingosine kinase 2 inhibitor | 0.071 0.021 CID_7271 0.076 0.018 CID_13618 0.071 0.021 CID_13619 | ||
| 0.142 | 0.056 | 0.168 | MAP kinase kinase inhibitor | 0.168 0.042 CID_7271 0.163 0.045 CID_13618 0.163 0.044 CID_13619 | CID_7271 | |
| 0.137 | 0.051 | 0.137 | Beta amyloid protein antagonist | 0.104 0.084 CID_7271 | ||
| 0.091 | 0.005 | 0.091 | Adenylate cyclase 1 inhibitor | 0.06 0.018 CID_7271 0.07 0.012 CID_13618 0.061 0.017 CID_13619 | ||
| 0.091 | 0.004 | 0.091 | Potassium channel Kv1.1 blocker | 0.042 0.02 CID_7271 0.039 0.025 CID_13618 0.042 0.021 CID_13619 | ||
| 0.101 | 0.015 | 0.101 | 5 Hydroxytryptamine 3 agonist | 0.06 0.048 CID_13618 | ||
| 0.097 | 0.011 | 0.097 | Potassium channel (Tandem pore domain) blocker | |||
| 0.092 | 0.006 | 0.092 | Glutamate (mGluR4) antagonist | 0.056 0.016 CID_7271 0.051 0.019 CID_13618 0.046 0.026 CID_13619 | ||
| 0.095 | 0.009 | 0.095 | Aconitate hydratase inhibitor | 0.079 0.014 CID_7271 0.079 0.014 CID_13618 0.07 0.018 CID_13619 | ||
| 0.091 | 0.005 | 0.091 | Kainate receptor 2 antagonist | 0.055 0.014 CID_7271 0.042 0.02 CID_13618 0.054 0.014 CID_13619 | ||
| 0.089 | 0.004 | 0.189 | ATP citrate lysase inhibitor | 0.189 0.002 CID_7271 0.088 0.004 CID_13618 0.151 0.003 CID_13619 | CID_7271 | |
| 0.099 | 0.014 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.043 CID_7271 0.079 0.038 CID_13618 0.073 0.053 CID_13619 | ||
| 0.11 | 0.025 | 0.13 | Glutamate decarboxylase inhibitor | 0.13 0.018 CID_7271 0.13 0.018 CID_13618 0.116 0.022 CID_13619 | CID_13618 | |
| 0.146 | 0.062 | 0.146 | Calcium channel blocker | |||
| 0.098 | 0.014 | 0.098 | CC chemokine 2 receptor antagonist | 0.069 0.025 CID_7271 0.056 0.036 CID_13618 0.059 0.033 CID_13619 | ||
| 0.229 | 0.144 | 0.229 | Antithrombotic | |||
| 0.14 | 0.056 | 0.14 | Antibacterial (Helicobacter pylori) | |||
| 0.151 | 0.067 | 0.151 | Protein kinase stimulant | 0.134 0.08 CID_7271 0.136 0.078 CID_13618 0.123 0.089 CID_13619 | ||
| 0.122 | 0.038 | 0.122 | Hedgehog signaling inhibitor | |||
| 0.109 | 0.025 | 0.109 | mTOR complex 2 inhibitor | 0.088 0.052 CID_7271 0.093 0.043 CID_13618 0.083 0.062 CID_13619 | ||
| 0.088 | 0.006 | 0.088 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.094 | 0.012 | 0.133 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.133 0.005 CID_7271 0.076 0.022 CID_13618 0.11 0.008 CID_13619 | CID_7271 | |
| 0.095 | 0.013 | 0.095 | Glutamate (mGluR7) antagonist | 0.08 0.028 CID_7271 0.082 0.025 CID_13618 0.072 0.039 CID_13619 | ||
| 0.086 | 0.004 | 0.086 | LFA antagonist | 0.028 0.019 CID_7271 0.031 0.015 CID_13619 | ||
| 0.102 | 0.021 | 0.102 | Ca(v)3.1 blocker | |||
| 0.215 | 0.134 | 0.318 | Hypoxia-inducible factor 1 alpha inhibitor | 0.24 0.11 CID_7271 0.318 0.058 CID_13618 0.248 0.102 CID_13619 | CID_13618 | |
| 0.096 | 0.015 | 0.096 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.086 0.018 CID_7271 0.086 0.018 CID_13618 0.077 0.022 CID_13619 | ||
| 0.092 | 0.011 | 0.092 | Glutamate (mGluR group III) agonist | 0.081 0.013 CID_7271 0.048 0.025 CID_13618 0.049 0.024 CID_13619 | ||
| 0.088 | 0.007 | 0.088 | Dihydroorotate oxidase inhibitor | 0.073 0.014 CID_7271 0.081 0.01 CID_13618 0.074 0.014 CID_13619 | ||
| 0.089 | 0.009 | 0.089 | Kainate receptor antagonist | 0.051 0.021 CID_7271 0.039 0.03 CID_13618 0.054 0.019 CID_13619 | ||
| 0.107 | 0.027 | 0.107 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 CID_7271 0.103 0.031 CID_13618 0.096 0.041 CID_13619 | ||
| 0.116 | 0.036 | 0.167 | Androgen antagonist | 0.167 0.018 CID_7271 0.115 0.036 CID_13618 0.147 0.023 CID_13619 | CID_7271 | |
| 0.11 | 0.031 | 0.11 | Glutamate receptor agonist | 0.068 0.065 CID_7271 0.099 0.038 CID_13619 | ||
| 0.083 | 0.004 | 0.083 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 CID_13619 | ||
| 0.112 | 0.033 | 0.117 | Carbonic anhydrase VI inhibitor | 0.106 0.036 CID_7271 0.117 0.03 CID_13618 0.097 0.041 CID_13619 | CID_13618 | |
| 0.095 | 0.017 | 0.095 | NMDA 2B receptor antagonist | 0.062 0.03 CID_7271 0.052 0.04 CID_13618 | ||
| 0.083 | 0.005 | 0.083 | Benzodiazepine antagonist | 0.05 0.027 CID_7271 0.051 0.025 CID_13619 | ||
| 0.083 | 0.006 | 0.083 | Purinergic P2X4 antagonist | 0.072 0.009 CID_7271 0.064 0.012 CID_13618 0.063 0.012 CID_13619 | ||
| 0.1 | 0.023 | 0.1 | Nav1.7 sodium channel blocker | 0.062 0.055 CID_7271 | ||
| 0.086 | 0.01 | 0.086 | 5 Hydroxytryptamine 2C agonist | 0.055 0.024 CID_7271 0.056 0.024 CID_13619 | ||
| 0.107 | 0.031 | 0.107 | ATPase (Vacuolar H+) inhibitor | 0.099 0.04 CID_7271 0.105 0.033 CID_13618 0.093 0.05 CID_13619 | ||
| 0.08 | 0.004 | 0.08 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.023 CID_7271 0.042 0.025 CID_13618 0.042 0.024 CID_13619 | ||
| 0.134 | 0.059 | 0.157 | Vanilloid 1 agonist | 0.157 0.032 CID_7271 0.138 0.052 CID_13618 0.144 0.045 CID_13619 | CID_7271 | |
| 0.153 | 0.078 | 0.213 | Melanin inhibitor | 0.172 0.057 CID_7271 0.213 0.036 CID_13618 0.155 0.075 CID_13619 | CID_13618 | |
| 0.082 | 0.007 | 0.082 | Substance P antagonist | |||
| 0.105 | 0.03 | 0.105 | Myeloperoxidase inhibitor | 0.1 0.035 CID_7271 0.094 0.043 CID_13618 0.089 0.05 CID_13619 | ||
| 0.108 | 0.033 | 0.108 | Interleukin 5 antagonist | 0.081 0.071 CID_13619 | ||
| 0.1 | 0.026 | 0.1 | Cannabinoid receptor agonist | |||
| 0.149 | 0.075 | 0.149 | Acetylcholine M1 receptor antagonist | |||
| 0.096 | 0.022 | 0.096 | Acetylcholine M5 receptor agonist | |||
| 0.093 | 0.019 | 0.093 | TRPA1 antagonist | 0.06 0.043 CID_7271 | ||
| 0.083 | 0.01 | 0.083 | Glutamate (mGluR5) agonist | |||
| 0.099 | 0.026 | 0.125 | Estrogen-related receptor beta agonist | 0.125 0.008 CID_7271 0.112 0.014 CID_13618 0.117 0.011 CID_13619 | CID_7271 | |
| 0.259 | 0.186 | 0.259 | DNA directed DNA polymerase inhibitor | 0.241 0.197 CID_13618 | ||
| 0.077 | 0.004 | 0.077 | Nerve growth factor antagonist | 0.052 0.015 CID_7271 0.054 0.014 CID_13618 0.052 0.016 CID_13619 | ||
| 0.089 | 0.016 | 0.096 | Prostaglandin F2 alpha antagonist | 0.096 0.013 CID_7271 0.086 0.018 CID_13619 | CID_7271 | |
| 0.081 | 0.009 | 0.081 | Dopamine D3 agonist | 0.065 0.012 CID_7271 0.045 0.023 CID_13619 | ||
| 0.081 | 0.008 | 0.081 | Glucose-6-phosphate isomerase inhibitor | 0.08 0.009 CID_7271 0.08 0.009 CID_13618 0.074 0.01 CID_13619 | ||
| 0.255 | 0.183 | 0.255 | Transcription factor inhibitor | |||
| 0.195 | 0.124 | 0.195 | Spasmolytic | 0.158 0.156 CID_7271 0.167 0.148 CID_13618 0.185 0.133 CID_13619 | ||
| 0.09 | 0.019 | 0.113 | Androgen agonist | 0.113 0.011 CID_7271 0.079 0.024 CID_13618 0.101 0.014 CID_13619 | CID_7271 | |
| 0.095 | 0.025 | 0.111 | Sphingosine 1-phosphate receptor antagonist | 0.084 0.038 CID_7271 0.111 0.016 CID_13618 0.089 0.031 CID_13619 | CID_13618 | |
| 0.077 | 0.007 | 0.102 | Dopamine D5 agonist | 0.102 0.004 CID_7271 0.102 0.004 CID_13618 0.091 0.005 CID_13619 | CID_13618 | |
| 0.099 | 0.029 | 0.099 | Aminopeptidase I inhibitor | 0.09 0.034 CID_7271 0.09 0.034 CID_13618 0.082 0.041 CID_13619 | ||
| 0.102 | 0.032 | 0.102 | Cathepsin G inhibitor | 0.07 0.053 CID_13618 | ||
| 0.128 | 0.058 | 0.128 | DNA repair enzyme inhibitor | 0.118 0.077 CID_7271 0.108 0.101 CID_13618 0.108 0.102 CID_13619 | ||
| 0.073 | 0.005 | 0.073 | p53 inhibitor | |||
| 0.104 | 0.036 | 0.104 | Carbonic anhydrase XIII inhibitor | 0.09 0.043 CID_7271 0.103 0.037 CID_13618 0.08 0.05 CID_13619 | ||
| 0.12 | 0.053 | 0.12 | Falcipain 3 inhibitor | |||
| 0.11 | 0.043 | 0.131 | Alcohol dehydrogenase inhibitor | 0.131 0.028 CID_7271 0.103 0.049 CID_13618 0.121 0.034 CID_13619 | CID_7271 | |
| 0.095 | 0.028 | 0.095 | Dopamine D4 antagonist | 0.064 0.039 CID_7271 0.055 0.045 CID_13619 | ||
| 0.071 | 0.005 | 0.071 | CXC chemokine 3 receptor antagonist | |||
| 0.123 | 0.057 | 0.154 | Microtubule formation inhibitor | 0.126 0.055 CID_7271 0.154 0.036 CID_13618 0.121 0.059 CID_13619 | CID_13618 | |
| 0.08 | 0.014 | 0.08 | Kallikrein 7 inhibitor | |||
| 0.203 | 0.137 | 0.322 | Lipoxygenase inhibitor | 0.226 0.117 CID_7271 0.322 0.061 CID_13618 0.258 0.095 CID_13619 | CID_13618 | |
| 0.078 | 0.013 | 0.078 | Glutamate (mGluR group I) agonist | |||
| 0.252 | 0.186 | 0.289 | Alpha-glucosidase inhibitor | 0.236 0.196 CID_7271 0.289 0.165 CID_13618 | CID_13618 | |
| 0.075 | 0.01 | 0.075 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 CID_7271 0.041 0.037 CID_13618 0.045 0.031 CID_13619 | ||
| 0.121 | 0.056 | 0.121 | GABA receptor agonist | |||
| 0.071 | 0.007 | 0.083 | Dopamine beta hydroxylase inhibitor | 0.083 0.005 CID_7271 0.078 0.005 CID_13618 0.072 0.007 CID_13619 | CID_7271 | |
| 0.078 | 0.014 | 0.078 | CC chemokine 3 receptor antagonist | 0.036 0.034 CID_7271 | ||
| 0.12 | 0.056 | 0.12 | Calcium channel (voltage-sensitive) blocker | |||
| 0.1 | 0.037 | 0.1 | Inducible nitric-oxide synthase inhibitor | 0.075 0.071 CID_7271 | ||
| 0.072 | 0.009 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.058 0.028 CID_7271 0.057 0.032 CID_13618 0.057 0.032 CID_13619 | ||
| 0.067 | 0.005 | 0.067 | Protein kinase (CK2) beta inhibitor | 0.046 0.009 CID_7271 0.042 0.011 CID_13618 0.048 0.008 CID_13619 | ||
| 0.169 | 0.106 | 0.169 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.167 0.107 CID_13618 0.155 0.121 CID_13619 | ||
| 0.07 | 0.007 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.04 0.025 CID_7271 0.046 0.02 CID_13618 0.037 0.03 CID_13619 | ||
| 0.066 | 0.004 | 0.131 | CF transmembrane conductance regulator antagonist | 0.088 0.003 CID_7271 0.131 0.002 CID_13618 0.089 0.003 CID_13619 | CID_13618 | |
| 0.131 | 0.068 | 0.152 | CC chemokine 6 receptor antagonist | 0.142 0.036 CID_7271 0.152 0.02 CID_13618 0.127 0.085 CID_13619 | CID_13618 | |
| 0.071 | 0.008 | 0.071 | GABA B receptor antagonist | 0.039 0.037 CID_7271 0.047 0.023 CID_13618 | ||
| 0.081 | 0.02 | 0.199 | Heat shock protein 90 beta antagonist | 0.199 0.004 CID_7271 0.094 0.013 CID_13618 0.144 0.005 CID_13619 | CID_7271 | |
| 0.093 | 0.031 | 0.093 | CC chemokine 5 receptor agonist | 0.083 0.053 CID_7271 0.086 0.045 CID_13618 0.081 0.059 CID_13619 | ||
| 0.083 | 0.021 | 0.083 | Calcium channel T-type blocker | |||
| 0.066 | 0.004 | 0.066 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.091 | 0.029 | 0.091 | Carbonic anhydrase VA inhibitor | 0.075 0.041 CID_7271 0.07 0.046 CID_13618 0.069 0.047 CID_13619 | ||
| 0.07 | 0.009 | 0.07 | Glutamate (mGluR group III) antagonist | 0.049 0.023 CID_7271 0.045 0.028 CID_13618 0.042 0.035 CID_13619 | ||
| 0.078 | 0.017 | 0.078 | Neurokinin antagonist | |||
| 0.065 | 0.004 | 0.065 | Vanilloid 3 antagonist | 0.047 0.011 CID_7271 0.045 0.013 CID_13618 0.046 0.012 CID_13619 | ||
| 0.119 | 0.059 | 0.119 | Photosensitizer | 0.108 0.074 CID_7271 0.111 0.07 CID_13618 0.101 0.087 CID_13619 | ||
| 0.089 | 0.029 | 0.178 | Dopamine D1 antagonist | 0.178 0.012 CID_7271 0.137 0.017 CID_13618 0.123 0.019 CID_13619 | CID_7271 | |
| 0.065 | 0.005 | 0.095 | CXC chemokine 2 receptor antagonist | 0.076 0.004 CID_7271 0.084 0.004 CID_13618 0.095 0.004 CID_13619 | CID_13619 | |
| 0.066 | 0.007 | 0.107 | Glucagon receptor antagonist | 0.097 0.004 CID_7271 0.055 0.009 CID_13618 0.107 0.004 CID_13619 | CID_13619 | |
| 0.075 | 0.015 | 0.075 | Epithelial sodium channel blocker | 0.065 0.022 CID_7271 0.054 0.04 CID_13618 0.057 0.033 CID_13619 | ||
| 0.121 | 0.062 | 0.175 | Protein kinase (CK2) alpha inhibitor | 0.135 0.051 CID_7271 0.175 0.031 CID_13618 0.151 0.041 CID_13619 | CID_13618 | |
| 0.142 | 0.083 | 0.142 | Insulin secretagoues | |||
| 0.081 | 0.022 | 0.081 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.107 | 0.049 | 0.107 | Phosphodiesterase 7B inhibitor | |||
| 0.083 | 0.024 | 0.083 | Argininosuccinate synthase inhibitor | 0.077 0.026 CID_7271 0.077 0.026 CID_13618 0.066 0.032 CID_13619 | ||
| 0.076 | 0.018 | 0.161 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.148 0.005 CID_7271 0.161 0.005 CID_13618 0.104 0.009 CID_13619 | CID_13618 | |
| 0.074 | 0.016 | 0.074 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.024 CID_7271 0.068 0.02 CID_13618 0.056 0.037 CID_13619 | ||
| 0.09 | 0.032 | 0.09 | Epoxide hydrolase inhibitor | |||
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | |||
| 0.089 | 0.031 | 0.126 | Carbonic anhydrase V inhibitor | 0.126 0.02 CID_7271 0.077 0.037 CID_13618 0.093 0.03 CID_13619 | CID_7271 | |
| 0.154 | 0.096 | 0.154 | Tumour necrosis factor antagonist | |||
| 0.071 | 0.014 | 0.071 | Aldosterone antagonist | 0.045 0.038 CID_7271 | ||
| 0.079 | 0.021 | 0.079 | Thromboxane antagonist | 0.052 0.039 CID_13618 | ||
| 0.092 | 0.035 | 0.109 | HIV-1 reverse transcriptase inhibitor | 0.109 0.027 CID_7271 | CID_7271 | |
| 0.062 | 0.004 | 0.062 | Corticotropin releasing factor 1 receptor antagonist | 0.02 0.019 CID_7271 | ||
| 0.106 | 0.049 | 0.109 | Prolactin inhibitor | 0.109 0.047 CID_7271 0.109 0.047 CID_13618 0.095 0.06 CID_13619 | CID_13618 | |
| 0.09 | 0.033 | 0.09 | Adenosine A3 receptor antagonist | 0.069 0.06 CID_7271 | ||
| 0.076 | 0.018 | 0.076 | AMPA receptor antagonist | 0.042 0.041 CID_13618 | ||
| 0.114 | 0.057 | 0.114 | Protein kinase C gamma inhibitor | |||
| 0.068 | 0.011 | 0.068 | Cholesterol esterase inhibitor | |||
| 0.087 | 0.03 | 0.087 | Glucagon-like peptide 1 agonist | |||
| 0.093 | 0.037 | 0.093 | Caspase 7 inhibitor | |||
| 0.069 | 0.013 | 0.069 | Secretase gamma inhibitor | |||
| 0.141 | 0.085 | 0.141 | Phospholipase A2 inhibitor | 0.138 0.089 CID_7271 0.125 0.108 CID_13618 0.13 0.101 CID_13619 | ||
| 0.122 | 0.066 | 0.158 | Adenylate cyclase inhibitor | 0.158 0.04 CID_7271 0.121 0.067 CID_13618 0.133 0.058 CID_13619 | CID_7271 | |
| 0.069 | 0.013 | 0.069 | Bromodomain-containing protein 3 inhibitor | |||
| 0.079 | 0.024 | 0.087 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 CID_7271 0.085 0.02 CID_13618 0.087 0.019 CID_13619 | CID_13619 | |
| 0.139 | 0.083 | 0.139 | Hemostatic | |||
| 0.127 | 0.071 | 0.141 | Toll-Like receptor 2 antagonist | 0.132 0.066 CID_7271 0.141 0.059 CID_13618 0.126 0.072 CID_13619 | CID_13618 | |
| 0.11 | 0.055 | 0.16 | Protein kinase (CK2) inhibitor | 0.123 0.046 CID_7271 0.16 0.029 CID_13618 0.146 0.034 CID_13619 | CID_13618 | |
| 0.089 | 0.034 | 0.089 | Lipase inhibitor | |||
| 0.063 | 0.009 | 0.063 | Dihydrofolate reductase inhibitor | 0.054 0.014 CID_7271 0.043 0.031 CID_13618 0.045 0.027 CID_13619 | ||
| 0.118 | 0.063 | 0.118 | Caspase 3 inhibitor | 0.101 0.09 CID_7271 0.104 0.086 CID_13618 | ||
| 0.077 | 0.024 | 0.077 | Cyclin B1 inhibitor | |||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | 0.05 0.014 CID_7271 0.053 0.011 CID_13618 0.05 0.014 CID_13619 | ||
| 0.094 | 0.041 | 0.113 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.113 0.032 CID_7271 0.107 0.034 CID_13618 0.097 0.039 CID_13619 | CID_7271 | |
| 0.06 | 0.007 | 0.06 | Integrin alpha2 antagonist | 0.037 0.025 CID_7271 0.037 0.025 CID_13618 0.036 0.028 CID_13619 | ||
| 0.076 | 0.024 | 0.076 | Carbonic anhydrase VB inhibitor | 0.058 0.037 CID_7271 0.063 0.032 CID_13618 0.051 0.044 CID_13619 | ||
| 0.207 | 0.156 | 0.257 | Thyroid hormone antagonist | 0.22 0.145 CID_7271 0.257 0.119 CID_13618 0.23 0.137 CID_13619 | CID_13618 | |
| 0.077 | 0.026 | 0.083 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.083 0.023 CID_7271 0.08 0.025 CID_13618 0.07 0.03 CID_13619 | CID_7271 | |
| 0.071 | 0.02 | 0.071 | Thromboxane A2 antagonist | 0.05 0.036 CID_13618 | ||
| 0.091 | 0.04 | 0.092 | Na+ K+ transporting ATPase inhibitor | 0.09 0.041 CID_7271 0.092 0.039 CID_13618 0.082 0.048 CID_13619 | CID_13618 | |
| 0.06 | 0.009 | 0.06 | Histamine H1 receptor agonist | |||
| 0.06 | 0.01 | 0.06 | Fumarate hydratase inhibitor | 0.054 0.012 CID_7271 0.054 0.012 CID_13618 0.047 0.015 CID_13619 | ||
| 0.182 | 0.132 | 0.202 | DNA damaging | 0.202 0.114 CID_13618 | CID_13618 | |
| 0.077 | 0.027 | 0.077 | Cannabinoid CB2 receptor agonist | |||
| 0.055 | 0.005 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.049 0.008 CID_7271 0.046 0.01 CID_13618 0.043 0.013 CID_13619 | ||
| 0.074 | 0.024 | 0.074 | GABA receptor antagonist | |||
| 0.06 | 0.01 | 0.06 | AMPA 4 receptor antagonist | 0.043 0.022 CID_7271 0.044 0.02 CID_13618 0.043 0.022 CID_13619 | ||
| 0.057 | 0.007 | 0.057 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.039 0.012 CID_7271 0.034 0.014 CID_13618 0.032 0.015 CID_13619 | ||
| 0.069 | 0.02 | 0.069 | 5 Hydroxytryptamine 7 agonist | |||
| 0.065 | 0.017 | 0.065 | Squalene epoxidase inhibitor | 0.051 0.032 CID_7271 0.051 0.032 CID_13618 0.049 0.036 CID_13619 | ||
| 0.201 | 0.153 | 0.244 | Thyroid hormone beta antagonist | 0.206 0.149 CID_7271 0.244 0.122 CID_13618 0.217 0.14 CID_13619 | CID_13618 | |
| 0.147 | 0.099 | 0.249 | Dual specificity phosphatase 3 inhibitor | 0.249 0.041 CID_7271 0.193 0.065 CID_13618 0.158 0.09 CID_13619 | CID_7271 | |
| 0.064 | 0.016 | 0.064 | Histamine H4 receptor antagonist | |||
| 0.083 | 0.035 | 0.101 | Dopamine agonist | 0.1 0.028 CID_7271 0.101 0.027 CID_13619 | CID_13619 | |
| 0.07 | 0.022 | 0.07 | Glucosylceramidase inhibitor | 0.053 0.042 CID_7271 0.053 0.042 CID_13618 0.052 0.044 CID_13619 | ||
| 0.064 | 0.017 | 0.064 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.038 CID_13619 | ||
| 0.06 | 0.013 | 0.06 | Thymidine kinase inhibitor | 0.056 0.015 CID_7271 0.052 0.018 CID_13618 0.046 0.022 CID_13619 | ||
| 0.058 | 0.012 | 0.087 | Phosphoglycerate kinase inhibitor | 0.087 0.008 CID_7271 0.066 0.01 CID_13618 0.06 0.011 CID_13619 | CID_7271 | |
| 0.062 | 0.015 | 0.071 | Nicotinic acid receptor 1 agonist | 0.071 0.013 CID_7271 0.06 0.016 CID_13619 | CID_7271 | |
| 0.071 | 0.025 | 0.071 | GABA A receptor antagonist | |||
| 0.074 | 0.028 | 0.074 | Alpha 2 adrenoreceptor agonist | |||
| 0.055 | 0.009 | 0.055 | Prostaglandin EP3 antagonist | |||
| 0.064 | 0.018 | 0.064 | Heparanase inhibitor | 0.056 0.031 CID_7271 0.055 0.034 CID_13618 0.052 0.04 CID_13619 | ||
| 0.179 | 0.133 | 0.3 | Immunostimulant | 0.196 0.122 CID_7271 0.3 0.078 CID_13618 0.214 0.112 CID_13619 | CID_13618 | |
| 0.102 | 0.056 | 0.102 | Nitric-oxide synthase inhibitor | |||
| 0.053 | 0.008 | 0.053 | VCAM-1 antagonist | 0.038 0.033 CID_7271 0.039 0.03 CID_13619 | ||
| 0.072 | 0.026 | 0.072 | Cyclin D1 inhibitor | |||
| 0.057 | 0.012 | 0.057 | Glutamate (mGluR group II) antagonist | 0.042 0.023 CID_7271 0.057 0.012 CID_13618 0.042 0.022 CID_13619 | ||
| 0.053 | 0.008 | 0.053 | VCAM antagonist | 0.038 0.033 CID_7271 0.039 0.03 CID_13619 | ||
| 0.054 | 0.009 | 0.054 | Delayed rectifier potassium channel blocker | |||
| 0.054 | 0.009 | 0.058 | Glutamate (mGluR8) agonist | 0.055 0.009 CID_7271 0.058 0.008 CID_13618 0.045 0.015 CID_13619 | CID_13618 | |
| 0.065 | 0.02 | 0.088 | Adenine nucleotide translocase inhibitor | 0.087 0.007 CID_7271 0.065 0.021 CID_13618 0.088 0.006 CID_13619 | CID_13619 | |
| 0.063 | 0.019 | 0.063 | CD45 antagonist | 0.057 0.024 CID_7271 0.053 0.03 CID_13618 0.056 0.025 CID_13619 | ||
| 0.094 | 0.05 | 0.094 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.119 | 0.076 | 0.219 | c-Src kinase inhibitor | 0.219 0.031 CID_7271 0.129 0.069 CID_13619 | CID_7271 | |
| 0.08 | 0.036 | 0.08 | Secretase beta inhibitor | |||
| 0.074 | 0.03 | 0.074 | Prostaglandin EP2 antagonist | |||
| 0.05 | 0.007 | 0.05 | Integrin alpha1beta1 antagonist | 0.037 0.031 CID_13618 | ||
| 0.047 | 0.005 | 0.047 | Integrin alpha2beta1 antagonist | 0.028 0.015 CID_7271 0.028 0.016 CID_13618 0.027 0.017 CID_13619 | ||
| 0.053 | 0.01 | 0.053 | AMPA 1 receptor antagonist | 0.027 0.022 CID_7271 0.026 0.023 CID_13619 | ||
| 0.104 | 0.062 | 0.116 | MAO A inhibitor | 0.104 0.062 CID_7271 0.095 0.068 CID_13618 0.116 0.055 CID_13619 | CID_13619 | |
| 0.059 | 0.017 | 0.059 | Dihydroorotase inhibitor | 0.04 0.039 CID_7271 | ||
| 0.077 | 0.034 | 0.077 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.066 | 0.024 | 0.066 | Dihydroorotate dehydrogenase inhibitor | 0.045 0.043 CID_13618 | ||
| 0.048 | 0.006 | 0.048 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.021 CID_7271 0.038 0.019 CID_13618 0.035 0.028 CID_13619 | ||
| 0.049 | 0.007 | 0.067 | CC chemokine 1 receptor antagonist | 0.067 0.005 CID_7271 0.029 0.013 CID_13618 0.043 0.008 CID_13619 | CID_7271 | |
| 0.073 | 0.032 | 0.09 | Aromatase inhibitor | 0.09 0.024 CID_7271 0.073 0.032 CID_13618 0.072 0.033 CID_13619 | CID_7271 | |
| 0.061 | 0.019 | 0.061 | Neurokinin 3 antagonist | |||
| 0.082 | 0.04 | 0.088 | MAP kinase kinase 7 inhibitor | 0.087 0.03 CID_7271 0.088 0.028 CID_13618 0.083 0.038 CID_13619 | CID_13618 | |
| 0.057 | 0.015 | 0.057 | Progesterone antagonist | 0.04 0.022 CID_7271 0.039 0.023 CID_13619 | ||
| 0.084 | 0.042 | 0.084 | Acetylcholine M4 receptor antagonist | |||
| 0.068 | 0.027 | 0.068 | Sphingosine kinase inhibitor | 0.055 0.048 CID_7271 0.059 0.041 CID_13618 0.054 0.051 CID_13619 | ||
| 0.063 | 0.022 | 0.063 | Bombesin 2 receptor antagonist | 0.045 0.042 CID_7271 0.045 0.042 CID_13619 | ||
| 0.061 | 0.02 | 0.061 | Melanocortin antagonist | |||
| 0.047 | 0.007 | 0.047 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.063 | 0.024 | 0.063 | Thromboxane synthase inhibitor | |||
| 0.044 | 0.005 | 0.044 | Thymidine phosphorylase inhibitor | 0.03 0.012 CID_7271 0.033 0.009 CID_13618 0.03 0.012 CID_13619 | ||
| 0.065 | 0.026 | 0.065 | Cyclin B2 inhibitor | |||
| 0.05 | 0.011 | 0.05 | Glutamate (mGluR4) agonist | 0.034 0.022 CID_7271 0.034 0.023 CID_13618 | ||
| 0.048 | 0.01 | 0.048 | Free fatty acid receptor 1 antagonist | 0.044 0.012 CID_7271 0.038 0.018 CID_13618 0.035 0.022 CID_13619 | ||
| 0.048 | 0.009 | 0.048 | Carnitine palmitoyltransferase inhibitor | |||
| 0.065 | 0.026 | 0.065 | Cyclin B inhibitor | |||
| 0.047 | 0.009 | 0.047 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.043 | 0.005 | 0.043 | Purinergic P2Y15 antagonist | 0.034 0.011 CID_7271 0.037 0.009 CID_13618 0.034 0.011 CID_13619 | ||
| 0.049 | 0.011 | 0.049 | Melanocortin 5 antagonist | |||
| 0.045 | 0.007 | 0.051 | Sodium/glucose cotransporter 2 inhibitor | 0.051 0.006 CID_7271 0.042 0.008 CID_13618 0.043 0.008 CID_13619 | CID_7271 | |
| 0.044 | 0.006 | 0.044 | 5 Hydroxytryptamine 6 agonist | |||
| 0.088 | 0.05 | 0.088 | Histamine H1 receptor antagonist | |||
| 0.05 | 0.013 | 0.05 | Sirtuin 2 inhibitor | |||
| 0.12 | 0.084 | 0.12 | Toll-Like receptor antagonist | |||
| 0.056 | 0.02 | 0.056 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.082 | 0.045 | 0.155 | Estrogen receptor alpha antagonist | 0.155 0.011 CID_7271 0.123 0.018 CID_13618 0.125 0.017 CID_13619 | CID_7271 | |
| 0.101 | 0.065 | 0.101 | Alpha 2c adrenoreceptor antagonist | |||
| 0.068 | 0.031 | 0.068 | EphB4 antagonist | 0.064 0.035 CID_7271 0.061 0.037 CID_13618 | ||
| 0.073 | 0.036 | 0.073 | Potassium channel (ATP-sensitive) blocker | |||
| 0.139 | 0.103 | 0.139 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.069 | 0.032 | 0.069 | Transcription factor RelA inhibitor | 0.06 0.054 CID_7271 0.062 0.049 CID_13618 | ||
| 0.109 | 0.073 | 0.109 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.076 | 0.04 | 0.083 | Peroxisome proliferator-activated receptor gamma antagonist | 0.083 0.03 CID_7271 0.066 0.064 CID_13618 0.073 0.046 CID_13619 | CID_7271 | |
| 0.064 | 0.028 | 0.064 | Toll-Like receptor 8 antagonist | |||
| 0.052 | 0.017 | 0.052 | Factor XIa inhibitor | |||
| 0.047 | 0.011 | 0.047 | Factor XI inhibitor | |||
| 0.051 | 0.016 | 0.051 | Dihydropteroate synthase inhibitor | 0.051 0.016 CID_7271 0.036 0.032 CID_13618 0.05 0.017 CID_13619 | ||
| 0.108 | 0.073 | 0.118 | CDK3/cyclin E inhibitor | 0.118 0.057 CID_7271 | CID_7271 | |
| 0.05 | 0.015 | 0.05 | Farnesoid X receptor agonist | 0.045 0.019 CID_7271 0.048 0.016 CID_13618 0.047 0.017 CID_13619 | ||
| 0.043 | 0.008 | 0.043 | Prostaglandin EP1 antagonist | |||
| 0.097 | 0.062 | 0.106 | Interleukin 1 beta converting enzyme inhibitor | 0.088 0.075 CID_7271 0.106 0.05 CID_13618 | CID_13618 | |
| 0.156 | 0.121 | 0.156 | Focal adhesion kinase 2 inhibitor | |||
| 0.061 | 0.026 | 0.061 | Alpha-mannosidase inhibitor | 0.057 0.032 CID_7271 0.057 0.03 CID_13618 0.053 0.038 CID_13619 | ||
| 0.05 | 0.015 | 0.05 | Bradykinin antagonist | |||
| 0.053 | 0.019 | 0.053 | Histamine H2 receptor agonist | |||
| 0.121 | 0.087 | 0.121 | Interleukin 1 antagonist | |||
| 0.054 | 0.019 | 0.054 | Geranyltranstransferase inhibitor | 0.043 0.032 CID_7271 0.041 0.035 CID_13618 | ||
| 0.065 | 0.031 | 0.065 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.049 | 0.016 | 0.049 | GABA uptake inhibitor | 0.037 0.031 CID_7271 0.04 0.026 CID_13618 | ||
| 0.058 | 0.026 | 0.058 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.052 | 0.019 | 0.052 | Guanylate cyclase inhibitor | 0.049 0.022 CID_7271 0.051 0.02 CID_13618 | ||
| 0.037 | 0.005 | 0.037 | Complement factor 1r inhibitor | |||
| 0.037 | 0.005 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 CID_7271 0.026 0.006 CID_13618 | ||
| 0.039 | 0.007 | 0.039 | MAP3K8 inhibitor | 0.029 0.02 CID_7271 | ||
| 0.048 | 0.016 | 0.048 | Arginase inhibitor | 0.036 0.026 CID_7271 0.035 0.027 CID_13618 0.033 0.028 CID_13619 | ||
| 0.042 | 0.011 | 0.042 | Uridine phosphorylase inhibitor | 0.037 0.013 CID_7271 0.031 0.017 CID_13618 0.036 0.014 CID_13619 | ||
| 0.039 | 0.007 | 0.039 | Kainate receptor 1 antagonist | 0.018 0.017 CID_7271 0.02 0.016 CID_13619 | ||
| 0.036 | 0.005 | 0.036 | ICAM 1 antagonist | 0.024 0.014 CID_7271 0.024 0.013 CID_13619 | ||
| 0.042 | 0.01 | 0.042 | Cyclophilin A inhibitor | |||
| 0.113 | 0.081 | 0.113 | Epidermal growth factor receptor kinase inhibitor | 0.11 0.085 CID_7271 | ||
| 0.08 | 0.049 | 0.08 | Alpha 2a adrenoreceptor antagonist | |||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | 0.033 0.009 CID_7271 0.034 0.008 CID_13618 0.03 0.012 CID_13619 | ||
| 0.044 | 0.014 | 0.079 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.079 0.005 CID_7271 0.074 0.005 CID_13618 0.065 0.007 CID_13619 | CID_7271 | |
| 0.048 | 0.018 | 0.048 | Acid-sensing ion channel blocker | |||
| 0.04 | 0.01 | 0.04 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 CID_7271 0.027 0.026 CID_13619 | ||
| 0.064 | 0.033 | 0.064 | Phosphodiesterase 1A inhibitor | |||
| 0.061 | 0.031 | 0.061 | Ornithine carbamoyltransferase inhibitor | 0.051 0.039 CID_7271 0.051 0.039 CID_13618 | ||
| 0.033 | 0.003 | 0.033 | Thromboxane A2 agonist | 0.021 0.005 CID_7271 0.025 0.004 CID_13618 0.022 0.005 CID_13619 | ||
| 0.042 | 0.013 | 0.042 | AMPA 3 receptor antagonist | |||
| 0.065 | 0.036 | 0.065 | Phosphodiesterase 1C inhibitor | |||
| 0.033 | 0.005 | 0.033 | Sodium/hydrogen exchanger inhibitor | |||
| 0.062 | 0.034 | 0.062 | Bcl-xL inhibitor | 0.057 0.051 CID_7271 | ||
| 0.034 | 0.005 | 0.034 | Imidazoline I1 receptor antagonist | |||
| 0.044 | 0.016 | 0.051 | RNA-directed RNA polymerase inhibitor | 0.05 0.013 CID_7271 0.051 0.012 CID_13618 0.051 0.012 CID_13619 | CID_13619 | |
| 0.033 | 0.005 | 0.033 | Complement factor 1s inhibitor | |||
| 0.036 | 0.008 | 0.036 | Prostaglandin H2 antagonist | 0.026 0.017 CID_13618 0.023 0.02 CID_13619 | ||
| 0.04 | 0.013 | 0.049 | Liver X receptor beta antagonist | 0.048 0.009 CID_7271 0.049 0.009 CID_13618 0.036 0.014 CID_13619 | CID_13618 | |
| 0.061 | 0.034 | 0.061 | Fatty acid synthase inhibitor | 0.061 0.034 CID_7271 0.058 0.038 CID_13619 | ||
| 0.032 | 0.005 | 0.032 | Cyclin T1 inhibitor | 0.017 0.014 CID_13618 | ||
| 0.064 | 0.037 | 0.064 | Acetylcholine M5 receptor antagonist | |||
| 0.044 | 0.017 | 0.09 | Nicotinic acid receptor agonist | 0.09 0.005 CID_7271 0.036 0.026 CID_13618 0.073 0.008 CID_13619 | CID_7271 | |
| 0.066 | 0.04 | 0.066 | Dopamine D3 antagonist | |||
| 0.033 | 0.006 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 CID_7271 0.022 0.019 CID_13618 0.022 0.019 CID_13619 | ||
| 0.05 | 0.024 | 0.05 | Opioid kappa receptor agonist | |||
| 0.055 | 0.029 | 0.067 | CXC chemokine 1 receptor antagonist | 0.06 0.022 CID_7271 0.067 0.015 CID_13618 0.057 0.025 CID_13619 | CID_13618 | |
| 0.048 | 0.021 | 0.053 | Liver X receptor alpha agonist | 0.037 0.035 CID_7271 0.053 0.017 CID_13618 | CID_13618 | |
| 0.035 | 0.009 | 0.036 | Sodium/glucose cotransporter inhibitor | 0.036 0.008 CID_7271 0.031 0.01 CID_13618 0.032 0.01 CID_13619 | CID_7271 | |
| 0.05 | 0.024 | 0.05 | Oxytocin agonist | 0.049 0.024 CID_7271 0.049 0.025 CID_13618 0.043 0.029 CID_13619 | ||
| 0.064 | 0.038 | 0.064 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.007 CID_7271 0.028 0.005 CID_13618 0.021 0.013 CID_13619 | ||
| 0.028 | 0.003 | 0.028 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 CID_7271 0.021 0.004 CID_13618 0.017 0.005 CID_13619 | ||
| 0.038 | 0.013 | 0.04 | Glutamate (mGluR2) antagonist | 0.028 0.024 CID_7271 0.04 0.012 CID_13618 0.027 0.025 CID_13619 | CID_13618 | |
| 0.044 | 0.019 | 0.044 | Potassium channel KCNQ activator | |||
| 0.044 | 0.019 | 0.044 | Delayed rectifier potassium channel activator | |||
| 0.033 | 0.008 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_7271 0.031 0.01 CID_13618 0.026 0.021 CID_13619 | ||
| 0.038 | 0.014 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.032 0.018 CID_7271 0.037 0.015 CID_13618 | ||
| 0.055 | 0.03 | 0.055 | Phosphodiesterase 7A inhibitor | |||
| 0.044 | 0.019 | 0.044 | Diamine oxidase inhibitor | |||
| 0.048 | 0.024 | 0.048 | Melanocortin 4 antagonist | |||
| 0.051 | 0.027 | 0.051 | Carbonic anhydrase VII inhibitor | 0.051 0.027 CID_7271 0.051 0.026 CID_13618 0.047 0.031 CID_13619 | ||
| 0.028 | 0.004 | 0.028 | CC chemokine 9 receptor antagonist | 0.017 0.013 CID_7271 0.018 0.01 CID_13618 0.016 0.014 CID_13619 | ||
| 0.121 | 0.097 | 0.121 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.129 | 0.106 | 0.129 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.127 0.109 CID_13619 | ||
| 0.034 | 0.01 | 0.042 | Prostaglandin EP2 agonist | 0.036 0.01 CID_7271 0.027 0.014 CID_13618 0.042 0.008 CID_13619 | CID_13619 | |
| 0.033 | 0.009 | 0.033 | Nicotinic acid receptor 2 antagonist | 0.026 0.02 CID_7271 0.028 0.017 CID_13618 | ||
| 0.032 | 0.008 | 0.032 | Geranylgeranyltransferase inhibitor | |||
| 0.088 | 0.065 | 0.094 | Thioredoxin inhibitor | 0.094 0.056 CID_7271 | CID_7271 | |
| 0.054 | 0.031 | 0.054 | Glucose-6-phosphate translocase inhibitor | |||
| 0.042 | 0.02 | 0.042 | Somatostatin 4 agonist | |||
| 0.037 | 0.015 | 0.037 | Cholesterol ester transfer protein antagonist | 0.03 0.024 CID_7271 0.029 0.026 CID_13618 0.034 0.019 CID_13619 | ||
| 0.094 | 0.072 | 0.094 | MAP kinase kinase kinase inhibitor | |||
| 0.03 | 0.008 | 0.03 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.03 | 0.009 | 0.032 | Prostaglandin F2 alpha agonist | 0.031 0.008 CID_7271 0.026 0.012 CID_13618 0.032 0.008 CID_13619 | CID_13619 | |
| 0.05 | 0.028 | 0.055 | Thymidylate synthase inhibitor | 0.055 0.022 CID_7271 0.052 0.025 CID_13618 0.046 0.033 CID_13619 | CID_7271 | |
| 0.035 | 0.014 | 0.035 | Bradykinin B1 receptor antagonist | |||
| 0.037 | 0.015 | 0.037 | Vanilloid 4 antagonist | |||
| 0.03 | 0.009 | 0.03 | Glutamate (mGluR1a) agonist | 0.02 0.019 CID_13618 | ||
| 0.026 | 0.005 | 0.026 | Integrin alphaLbeta2 antagonist | |||
| 0.026 | 0.005 | 0.026 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 CID_7271 0.02 0.01 CID_13618 | ||
| 0.052 | 0.031 | 0.052 | Potassium channel (Inward rectifier) blocker | |||
| 0.037 | 0.017 | 0.037 | Dipeptidyl peptidase II inhibitor | |||
| 0.024 | 0.003 | 0.024 | Thromboxane agonist | 0.019 0.004 CID_7271 0.012 0.006 CID_13618 0.02 0.004 CID_13619 | ||
| 0.037 | 0.017 | 0.037 | Adenosine uptake inhibitor | |||
| 0.058 | 0.038 | 0.058 | Carbonic anhydrase IX inhibitor | 0.047 0.045 CID_13618 | ||
| 0.032 | 0.012 | 0.032 | DNA polymerase III inhibitor | |||
| 0.029 | 0.01 | 0.029 | Kainate receptor 5 antagonist | |||
| 0.048 | 0.029 | 0.048 | Farnesyltransferase inhibitor | |||
| 0.057 | 0.037 | 0.057 | Leukotriene C antagonist | 0.054 0.045 CID_7271 0.057 0.037 CID_13618 | ||
| 0.046 | 0.027 | 0.046 | Dipeptidyl peptidase IV inhibitor | |||
| 0.058 | 0.039 | 0.058 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.038 | 0.019 | 0.038 | Glutamate (mGluR8) antagonist | |||
| 0.035 | 0.016 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.008 CID_7271 0.039 0.011 CID_13618 0.038 0.012 CID_13619 | CID_7271 | |
| 0.047 | 0.028 | 0.047 | Mannosidase inhibitor | 0.044 0.034 CID_7271 0.044 0.033 CID_13618 | ||
| 0.101 | 0.082 | 0.101 | Anesthetic local | |||
| 0.023 | 0.004 | 0.023 | Integrin beta2 antagonist | |||
| 0.043 | 0.025 | 0.043 | Neurokinin 1 antagonist | |||
| 0.033 | 0.014 | 0.033 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.043 | 0.025 | 0.043 | Sphingosine kinase 1 inhibitor | |||
| 0.048 | 0.029 | 0.048 | Oleamide hydrolase inhibitor | |||
| 0.035 | 0.017 | 0.038 | Prostaglandin agonist | 0.035 0.017 CID_7271 0.028 0.026 CID_13618 0.038 0.014 CID_13619 | CID_13619 | |
| 0.023 | 0.005 | 0.023 | Complement factor D inhibitor | |||
| 0.051 | 0.033 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.022 | 0.004 | 0.022 | Corticotropin releasing factor antagonist | |||
| 0.098 | 0.08 | 0.104 | Mucolytic | 0.103 0.073 CID_7271 0.104 0.072 CID_13618 0.092 0.09 CID_13619 | CID_13618 | |
| 0.042 | 0.024 | 0.042 | Melanocortin 1 antagonist | |||
| 0.081 | 0.063 | 0.081 | Transforming growth factor beta 3 antagonist | |||
| 0.061 | 0.044 | 0.072 | Beta 2 adrenoreceptor agonist | 0.072 0.016 CID_7271 0.068 0.024 CID_13618 0.068 0.024 CID_13619 | CID_7271 | |
| 0.046 | 0.028 | 0.046 | Carbonic anhydrase IV inhibitor | |||
| 0.059 | 0.041 | 0.059 | Ca(v)3.2 blocker | |||
| 0.072 | 0.054 | 0.072 | CDC25A inhibitor | 0.066 0.065 CID_13619 | ||
| 0.056 | 0.038 | 0.056 | Carbonic anhydrase I inhibitor | |||
| 0.085 | 0.068 | 0.085 | Phosphodiesterase I inhibitor | |||
| 0.022 | 0.005 | 0.022 | Prokineticin receptor 1 antagonist | |||
| 0.039 | 0.022 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.032 | 0.015 | 0.032 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.035 | 0.018 | 0.04 | HCV NS5B polymerase inhibitor | 0.037 0.016 CID_7271 0.04 0.014 CID_13618 0.039 0.015 CID_13619 | CID_13618 | |
| 0.043 | 0.027 | 0.049 | CDK5/p25 inhibitor | 0.049 0.022 CID_7271 0.042 0.028 CID_13618 | CID_7271 | |
| 0.034 | 0.018 | 0.034 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.02 | 0.004 | 0.02 | Carbonic anhydrase XI inhibitor | |||
| 0.028 | 0.012 | 0.029 | Vanilloid 2 agonist | 0.029 0.01 CID_7271 0.029 0.01 CID_13618 0.027 0.014 CID_13619 | CID_13618 | |
| 0.023 | 0.007 | 0.023 | Alpha 2c adrenoreceptor agonist | |||
| 0.026 | 0.01 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_7271 0.025 0.01 CID_13618 0.024 0.013 CID_13619 | CID_7271 | |
| 0.019 | 0.004 | 0.019 | Progesterone receptor A antagonist | 0.01 0.006 CID_7271 0.01 0.005 CID_13618 0.01 0.005 CID_13619 | ||
| 0.034 | 0.019 | 0.034 | GHS receptor antagonist | |||
| 0.07 | 0.055 | 0.07 | Orexin receptor 1 antagonist | |||
| 0.028 | 0.012 | 0.028 | Acid ceramidase inhibitor | |||
| 0.052 | 0.037 | 0.052 | Dipeptidyl peptidase inhibitor | |||
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.022 | 0.007 | 0.022 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.05 | 0.036 | 0.05 | Prolyl endopeptidase inhibitor | |||
| 0.022 | 0.007 | 0.022 | CXC chemokine 5 receptor antagonist | |||
| 0.07 | 0.056 | 0.07 | Vanilloid antagonist | |||
| 0.022 | 0.008 | 0.022 | Dipeptidyl peptidase IX inhibitor | |||
| 0.035 | 0.021 | 0.038 | Liver X receptor beta agonist | 0.038 0.017 CID_7271 0.035 0.02 CID_13618 0.03 0.028 CID_13619 | CID_7271 | |
| 0.03 | 0.016 | 0.033 | Estrogen-related receptor gamma antagonist | 0.032 0.012 CID_7271 0.033 0.011 CID_13618 0.03 0.015 CID_13619 | CID_13618 | |
| 0.047 | 0.033 | 0.047 | Potassium channel Kv1.3 blocker | |||
| 0.038 | 0.025 | 0.038 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.035 | 0.022 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.034 0.024 CID_7271 0.031 0.03 CID_13619 | ||
| 0.039 | 0.026 | 0.039 | Vascular adhesion protein 1 inhibitor | |||
| 0.056 | 0.043 | 0.056 | Glutamate (mGluR1) antagonist | |||
| 0.057 | 0.044 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.04 | 0.027 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.053 | 0.04 | 0.053 | Acetylcholine muscarinic agonist | |||
| 0.026 | 0.014 | 0.028 | Prostaglandin E2 agonist | 0.024 0.015 CID_7271 0.028 0.012 CID_13619 | CID_13619 | |
| 0.043 | 0.031 | 0.043 | Stearoyl-CoA desaturase inhibitor | |||
| 0.05 | 0.038 | 0.05 | Carbonic anhydrase XII inhibitor | |||
| 0.037 | 0.025 | 0.053 | Inosine monophosphate dehydrogenase inhibitor | 0.032 0.031 CID_7271 0.053 0.013 CID_13618 0.037 0.024 CID_13619 | CID_13618 | |
| 0.038 | 0.026 | 0.038 | TRPM8 blocker | |||
| 0.02 | 0.008 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 CID_7271 0.021 0.008 CID_13618 0.024 0.006 CID_13619 | CID_7271 | |
| 0.03 | 0.018 | 0.03 | Thrombin receptor antagonist | |||
| 0.221 | 0.21 | 0.221 | DNA polymerase beta inhibitor | |||
| 0.063 | 0.051 | 0.063 | Neuronal nicotinic receptor antagonist | |||
| 0.031 | 0.02 | 0.031 | Epoxide hydrolase 1 inhibitor | |||
| 0.014 | 0.003 | 0.014 | DNA polymerase III subunit alpha inhibitor | 0.008 0.004 CID_13618 | ||
| 0.119 | 0.108 | 0.165 | Src kinase inhibitor | 0.165 0.074 CID_7271 | CID_7271 | |
| 0.052 | 0.042 | 0.052 | Carbonic anhydrase II inhibitor | 0.052 0.042 CID_13618 0.049 0.045 CID_13619 | ||
| 0.024 | 0.014 | 0.024 | Urotensin II antagonist | 0.021 0.017 CID_7271 | ||
| 0.047 | 0.037 | 0.047 | Cytokine production stimulant | |||
| 0.013 | 0.003 | 0.013 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_7271 0.01 0.004 CID_13618 0.008 0.004 CID_13619 | ||
| 0.028 | 0.018 | 0.028 | VLA-4 antagonist | |||
| 0.029 | 0.019 | 0.029 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.061 | 0.051 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.073 | 0.063 | 0.073 | Acetylcholine nicotinic antagonist | |||
| 0.033 | 0.023 | 0.033 | Calcium release-activated channel blocker | |||
| 0.05 | 0.04 | 0.05 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.057 | 0.048 | 0.057 | Carbonic anhydrase inhibitor | 0.055 0.051 CID_13618 0.055 0.051 CID_13619 | ||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase VIII inhibitor | |||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase X inhibitor | |||
| 0.089 | 0.081 | 0.089 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.047 | 0.038 | 0.047 | Topoisomerase II beta inhibitor | |||
| 0.027 | 0.019 | 0.027 | Myristoyl transferase inhibitor | |||
| 0.018 | 0.01 | 0.018 | G-protein-coupled receptor 120 agonist | 0.016 0.014 CID_13618 0.017 0.012 CID_13619 | ||
| 0.018 | 0.01 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_7271 0.019 0.009 CID_13618 0.018 0.01 CID_13619 | CID_13618 | |
| 0.017 | 0.01 | 0.017 | Nicotinic alpha4 receptor agonist | |||
| 0.037 | 0.03 | 0.037 | Cathepsin L1 inhibitor | |||
| 0.047 | 0.041 | 0.047 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.018 | 0.012 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.043 | 0.037 | 0.063 | Adenosine deaminase inhibitor | 0.063 0.018 CID_13618 0.044 0.036 CID_13619 | CID_13618 | |
| 0.034 | 0.028 | 0.034 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.045 | 0.039 | 0.045 | Carbonic anhydrase XIV inhibitor | |||
| 0.036 | 0.03 | 0.074 | Urate transporter 1 inhibitor | 0.074 0.009 CID_7271 0.068 0.011 CID_13618 0.052 0.018 CID_13619 | CID_7271 | |
| 0.06 | 0.055 | 0.06 | Alpha adrenoreceptor agonist | |||
| 0.029 | 0.023 | 0.029 | Acetylcholine M4 receptor agonist | |||
| 0.01 | 0.004 | 0.01 | Free fatty acid receptor 2 antagonist | |||
| 0.041 | 0.036 | 0.041 | AICAR transformylase inhibitor | |||
| 0.025 | 0.02 | 0.025 | Calcium-sensing receptor agonist | |||
| 0.024 | 0.018 | 0.024 | Kainate receptor 4 antagonist | |||
| 0.025 | 0.02 | 0.025 | Sigma 2 receptor antagonist | |||
| 0.018 | 0.014 | 0.018 | Histamine H4 receptor agonist | |||
| 0.037 | 0.033 | 0.037 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.014 | 0.01 | 0.014 | Prostaglandin EP4 agonist | |||
| 0.015 | 0.011 | 0.015 | NMDA receptor phencyclidine site antagonist | |||
| 0.052 | 0.048 | 0.052 | Cathepsin L inhibitor | |||
| 0.06 | 0.057 | 0.06 | CDC7 inhibitor | |||
| 0.011 | 0.008 | 0.011 | Melatonin 5 antagonist | |||
| 0.056 | 0.053 | 0.056 | Ryanodine receptor antagonist | |||
| 0.037 | 0.034 | 0.037 | Leukotriene C4 antagonist | 0.037 0.034 CID_13618 | ||
| 0.02 | 0.017 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.031 | 0.029 | 0.031 | Retinoid X alpha receptor agonist | 0.031 0.029 CID_7271 | ||
| 0.012 | 0.01 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.057 | 0.054 | 0.057 | I kappa B kinase 2 inhibitor | |||
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.103 | 0.101 | 0.11 | Glycogen synthase kinase-3 alpha inhibitor | 0.11 0.093 CID_7271 0.11 0.093 CID_13618 | CID_13618 | |
| 0.023 | 0.021 | 0.023 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.051 | 0.049 | 0.051 | MAP kinase kinase 9 inhibitor | |||
| 0.075 | 0.073 | 0.075 | Alpha 2 adrenoreceptor antagonist | |||
| 0.059 | 0.057 | 0.059 | Interferon inducer | |||
| 0.018 | 0.016 | 0.018 | Integrin beta7 antagonist | |||
| 0.071 | 0.07 | 0.071 | Protein kinase A inhibitor | |||
| 0.233 | 0.232 | 0.271 | Cyclophilin D inhibitor | 0.271 0.19 CID_7271 0.259 0.203 CID_13619 | CID_7271 | |
| 0.019 | 0.018 | 0.019 | Factor XIII inhibitor | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.011 | 0.01 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.006 CID_7271 0.011 0.009 CID_13618 0.013 0.008 CID_13619 | CID_7271 | |
| 0.049 | 0.048 | 0.058 | Beta 1 adrenoreceptor antagonist | 0.058 0.038 CID_7271 | CID_7271 | |
| 0.093 | 0.092 | 0.093 | MAP kinase 13 inhibitor | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.069 | 0.068 | 0.069 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.02 | 0.019 | 0.02 | Dopamine autoreceptor agonist | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.037 | 0.036 | 0.037 | Acetylcholine M1 receptor agonist | |||
| 0.024 | 0.023 | 0.046 | Thyroid hormone agonist | 0.046 0.005 CID_7271 0.036 0.008 CID_13618 0.031 0.011 CID_13619 | CID_7271 | |
| 0.071 | 0.071 | 0.098 | Adrenaline agonist | 0.098 0.038 CID_7271 0.08 0.057 CID_13618 0.082 0.054 CID_13619 | CID_7271 | |
| 0.061 | 0.062 | 0.072 | Dopamine antagonist | 0.072 0.052 CID_7271 0.062 0.061 CID_13619 | CID_7271 | |
| 0.068 | 0.069 | 0.079 | Keratolytic | 0.079 0.05 CID_7271 0.079 0.05 CID_13618 0.071 0.062 CID_13619 | CID_13618 | |
| 0.074 | 0.075 | 0.079 | Epidermal growth factor antagonist | 0.079 0.067 CID_7271 | CID_7271 | |
| 0.056 | 0.057 | 0.164 | CDC25B inhibitor | 0.164 0.005 CID_13618 0.164 0.005 CID_13619 | CID_13619 | |
| 0.004 | 0.007 | 0.011 | Insulin like growth factor 3 antagonist | 0.011 0.002 CID_7271 0.01 0.003 CID_13619 | CID_7271 | |
| 0.037 | 0.043 | 0.061 | Sphingosine 1-phosphate receptor agonist | 0.061 0.016 CID_7271 0.041 0.036 CID_13619 | CID_7271 | |
| 0.042 | 0.048 | 0.077 | Aldose reductase inhibitor | 0.047 0.042 CID_7271 0.068 0.028 CID_13618 0.077 0.024 CID_13619 | CID_13619 | |
| 0.016 | 0.023 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 CID_7271 0.018 0.016 CID_13618 | CID_13618 | |
| 0.012 | 0.019 | 0.014 | Integrin beta6 antagonist | 0.014 0.01 CID_7271 | CID_7271 | |
| 0.239 | 0.247 | 0.299 | MAP kinase 1 inhibitor | 0.245 0.239 CID_7271 0.299 0.181 CID_13618 0.277 0.205 CID_13619 | CID_13618 | |
| 0.081 | 0.09 | 0.095 | Xanthine oxidase inhibitor | 0.095 0.064 CID_7271 0.09 0.071 CID_13618 0.084 0.083 CID_13619 | CID_7271 | |
| 0.055 | 0.065 | 0.071 | Beta adrenoreceptor antagonist | 0.071 0.037 CID_7271 0.071 0.037 CID_13618 0.066 0.044 CID_13619 | CID_13618 | |
| 0.123 | 0.133 | 0.33 | Dual specificity phosphatase inhibitor | 0.215 0.048 CID_7271 0.33 0.024 CID_13618 0.139 0.108 CID_13619 | CID_13618 | |
| 0.041 | 0.052 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.025 CID_7271 0.044 0.036 CID_13618 0.044 0.034 CID_13619 | CID_7271 | |
| 0.031 | 0.042 | 0.102 | Estradiol 17 beta-dehydrogenase inhibitor | 0.102 0.01 CID_7271 0.086 0.012 CID_13618 0.063 0.018 CID_13619 | CID_7271 | |
| 0.005 | 0.018 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 CID_7271 0.009 0.006 CID_13618 | CID_7271 | |
| 0.039 | 0.053 | 0.054 | Beta 2 adrenoreceptor antagonist | 0.047 0.041 CID_7271 0.054 0.031 CID_13618 0.049 0.039 CID_13619 | CID_13618 | |
| 0.031 | 0.051 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | 0.053 0.017 CID_7271 | CID_7271 | |
| 0.013 | 0.034 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.013 CID_7271 | CID_7271 | |
| 0.009 | 0.03 | 0.017 | Somatostatin 2 agonist | 0.017 0.008 CID_7271 0.013 0.012 CID_13619 | CID_7271 | |
| 0.127 | 0.149 | 0.148 | I kappa B kinase epsilon inhibitor | 0.148 0.121 CID_13618 | CID_13618 | |
| 0.18 | 0.203 | 0.429 | Caspase 3 stimulant | 0.207 0.159 CID_7271 0.429 0.036 CID_13618 0.406 0.043 CID_13619 | CID_13618 | |
| 0.011 | 0.041 | 0.047 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.047 0.007 CID_7271 0.039 0.009 CID_13618 0.023 0.015 CID_13619 | CID_7271 | |
| 0.034 | 0.068 | 0.052 | Xanthine dehydrogenase inhibitor | 0.052 0.044 CID_7271 | CID_7271 | |
| 0.099 | 0.135 | 0.14 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.14 0.084 CID_13618 | CID_13618 | |
| 0.018 | 0.055 | 0.033 | Liver X receptor alpha antagonist | 0.03 0.019 CID_7271 0.033 0.015 CID_13618 | CID_13618 | |
| 0.022 | 0.068 | 0.049 | Dopamine D2 agonist | 0.043 0.032 CID_7271 0.042 0.033 CID_13618 0.049 0.027 CID_13619 | CID_13619 | |
| 0.02 | 0.067 | 0.09 | Dopamine D5 antagonist | 0.09 0.01 CID_7271 0.071 0.015 CID_13618 0.052 0.024 CID_13619 | CID_7271 | |
| 0.077 | 0.125 | 0.12 | Alkylator | 0.12 0.068 CID_13618 | CID_13618 | |
| 0.036 | 0.084 | 0.054 | Acetylcholine M3 receptor antagonist | 0.054 0.05 CID_7271 | CID_7271 | |
| 0.015 | 0.071 | 0.029 | Liver X receptor antagonist | 0.029 0.024 CID_13618 | CID_13618 | |
| 0.046 | 0.116 | 0.071 | ErbB-2 antagonist | 0.071 0.058 CID_13618 | CID_13618 | |
| 0.019 | 0.098 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.022 CID_7271 | CID_7271 | |
| 0.064 | 0.148 | 0.123 | Vanilloid agonist | 0.123 0.017 CID_7271 0.102 0.031 CID_13619 | CID_7271 | |
| 0.019 | 0.114 | 0.037 | Estrogen-related receptor beta antagonist | 0.035 0.018 CID_7271 0.037 0.014 CID_13618 0.034 0.019 CID_13619 | CID_13618 | |
| 0.042 | 0.151 | 0.145 | HIV-1 integrase inhibitor | 0.101 0.024 CID_7271 0.145 0.009 CID_13618 0.072 0.046 CID_13619 | CID_13618 | |
| 0.078 | 0.192 | 0.174 | Protein-tyrosine phosphatase inhibitor | 0.174 0.06 CID_7271 0.139 0.091 CID_13618 0.128 0.103 CID_13619 | CID_7271 | |
| 0.007 | 0.123 | 0.038 | Thyroid hormone alpha agonist | 0.038 0.003 CID_7271 0.023 0.005 CID_13618 0.02 0.007 CID_13619 | CID_7271 | |
| 0.096 | 0.224 | 0.135 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.135 0.13 CID_13618 | CID_13618 | |
| 0.086 | 0.22 | 0.251 | Interleukin antagonist | 0.226 0.071 CID_13618 0.251 0.061 CID_13619 | CID_13619 | |
| 0.018 | 0.166 | 0.053 | Raf kinase C inhibitor | 0.053 0.048 CID_7271 | CID_7271 | |
| 0.051 | 0.201 | 0.392 | Estrogen receptor beta antagonist | 0.392 0.004 CID_7271 0.204 0.009 CID_13618 0.286 0.005 CID_13619 | CID_7271 | |
| 0.008 | 0.169 | 0.189 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.189 0.004 CID_7271 0.136 0.004 CID_13618 0.108 0.005 CID_13619 | CID_7271 | |
| 0.024 | 0.189 | 0.099 | Leukotriene synthesis inhibitor | 0.099 0.027 CID_13618 | CID_13618 | |
| 0.07 | 0.239 | 0.204 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.204 0.064 CID_13618 | CID_13618 | |
| 0.004 | 0.177 | 0.168 | Estrogen receptor alpha agonist | 0.168 0.005 CID_7271 0.042 0.02 CID_13618 0.115 0.007 CID_13619 | CID_7271 | |
| 0.058 | 0.235 | 0.382 | Estrogen antagonist | 0.369 0.005 CID_7271 0.291 0.006 CID_13618 0.382 0.005 CID_13619 | CID_13619 | |
| 0.133 | 0.316 | 0.213 | Apoptosis antagonist | 0.213 0.163 CID_13618 0.213 0.164 CID_13619 | CID_13619 | |
| 0.087 | 0.29 | 0.142 | Death-associated protein kinase 1 inhibitor | 0.142 0.053 CID_7271 | CID_7271 | |
| 0.008 | 0.226 | 0.049 | Catechol O-methyltransferase inhibitor | 0.049 0.009 CID_7271 0.037 0.016 CID_13618 0.036 0.018 CID_13619 | CID_7271 | |
| 0.004 | 0.23 | 0.036 | Thyroid hormone alpha antagonist | 0.031 0.005 CID_7271 0.036 0.005 CID_13618 0.017 0.01 CID_13619 | CID_13618 | |
| 0.054 | 0.284 | 0.527 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.527 0.01 CID_13618 | CID_13618 | |
| 0.056 | 0.291 | 0.514 | Dyrk kinase inhibitor | 0.514 0.013 CID_13618 | CID_13618 | |
| 0.011 | 0.263 | 0.127 | HIV-1 integrase (Strand Transfer) inhibitor | 0.127 0.015 CID_13618 | CID_13618 | |
| 0.051 | 0.32 | 0.208 | Interleukin 4 antagonist | 0.208 0.02 CID_7271 0.179 0.03 CID_13619 | CID_7271 | |
| 0.012 | 0.301 | 0.136 | HIV-1 integrase (3'-Processing) inhibitor | 0.056 0.052 CID_7271 0.136 0.016 CID_13618 | CID_13618 | |
| 0.003 | 0.335 | 0.195 | Estrogen receptor beta agonist | 0.195 0.005 CID_7271 0.028 0.024 CID_13618 0.151 0.007 CID_13619 | CID_7271 | |
| 0.005 | 0.36 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CID_7271 | CID_7271 | |
| 0.011 | 0.379 | 0.084 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.075 0.06 CID_7271 0.084 0.048 CID_13619 | CID_13619 | |
| 0.057 | 0.455 | 0.436 | Immunosuppressant | 0.252 0.146 CID_7271 0.436 0.051 CID_13618 0.375 0.074 CID_13619 | CID_13618 | |
| 0.023 | 0.429 | 0.36 | Uric acid excretion stimulant | 0.087 0.069 CID_7271 0.36 0.004 CID_13618 0.136 0.029 CID_13619 | CID_13618 | |
| 0.004 | 0.44 | 0.182 | Estrogen agonist | 0.182 0.009 CID_7271 0.075 0.025 CID_13618 0.113 0.015 CID_13619 | CID_7271 | |
| 0.027 | 0.513 | 0.171 | Free radical scavenger | 0.171 0.123 CID_7271 | CID_7271 | |
| 0.082 | 0.58 | 0.164 | Peptidyltransferase inhibitor | 0.164 0.16 CID_13618 | CID_13618 | |
| 0.017 | 0.537 | 0.099 | Chelator | 0.099 0.078 CID_7271 | CID_7271 | |
| 0.013 | 0.708 | 0.191 | Antioxidant | 0.191 0.121 CID_7271 0.171 0.141 CID_13618 | CID_7271 | |
| 0.004 | 0.702 | 0.038 | Nicotinic acid receptor 2 agonist | 0.038 0.022 CID_7271 | CID_7271 | |
| 0.003 | 0.787 | 0.089 | Sphingosine 1-phosphate receptor 3 agonist | 0.089 0.008 CID_7271 0.043 0.02 CID_13619 | CID_7271 | |
| 0.017 | 0.916 | 0.096 | Transcription factor NF kappa B stimulant | 0.096 0.043 CID_7271 | CID_7271 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |